Chronic Motor and Vocal Tic Disorder

Synonym
Gilles de la Tourette Disorder
Combined Vocal and Multiple Motor Tic Disorder
Tourette's Disease
Tourette Disorder
Tourette's Syndrome
Tic Disorder, Combined Vocal and Multiple Motor
Combined Multiple Motor and Vocal Tic Disorder
Tourette Disease
Gilles de la Tourette's Disease
Gilles De La Tourette's Syndrome
Gilles de la Tourette Syndrome
Chronic Motor and Vocal Tic Disorder
Multiple Motor and Vocal Tic Disorder, Combined
Tourette's Disorder

Excerpt	Reference
"Gilles de la Tourette Syndrome is a condition combining organic and psychogenic features existing in the interface between two etiologies."	( Pinta, ER, 1977)
"Gilles de la Tourette syndrome is a neuropsychiatric disease with a childhood onset below age 16, characterized by chronic involuntary movements, obsessions, compulsions, utterances, echolalia, coprolalia and aggressive behavior symptoms."	( Yaryura-Tobias, JA, 1979)
"Six cases of Gilles de la Tourette's syndrome are discussed in the light of conflicting views on the aetiology of the condition."	( Fernando, SJ, 1976)
"The Gilles de la Tourette syndrome is a disorder whose etiology and pathogenesis are little understood."	( Evans, K; Lascelles, P; Robertson, M; Robinson, A; Trimble, M, 1987)
"Gilles de la Tourette's syndrome is a hyperkinetic movement disorder in which an etiological role for dopaminergic hyperactivity has been proposed."	( Karson, CN; Kaufmann, CA; Shapiro, AK; Shapiro, E, 1985)
"Tourette's syndrome is a chronic tic disorder in which motor and vocal tics begin in childhood, persist to adulthood, and occur predominantly in males, often in a familial setting."	( Butler, IJ, 1984)
"A brief review of Gilles de la Tourette's disease is presented."	( Carlson, JC; Messiha, FS, 1983)
"Tourette's syndrome is a widely misunderstood chronic disorder that develops in childhood and is usually lifelong."	( Baird, PA; Connolly, JE; Freeman, RD, 1984)
"Gilles de la Tourette syndrome is frequently associated with symptoms characteristic of hyperactivity and often goes unrecognized for long periods of time."	( Sleator, EK, 1980)
"Tourette's syndrome is a disorder of central nervous system functioning in which the most easily recognized symptoms of involuntary movements and vocalizations have been found to be responsive, in many cases, to pharmacotherapy with haloperidol."	( O'Quinn, AN; Thompson, RJ, 1980)
"Tourette's syndrome is a fascinating, complex, hereditary, neuropsychiatric spectrum disorder in which the tics are only one of many symptoms."	( Comings, DE, 1995)
"Gilles de la Tourette syndrome is characterized by (a) onset usually in childhood and adolescence between 2 and 15 years of age, (b) violent facial tics and coprolalia, (c) increased excitability and apathy, (d) progressive increase in the intensity of symptoms, and (e) a chronic course."	( Johnson, FY, 1995)
"Tourette's disorder is characterized by chronic fluctuating motor and vocal tics."	( Cohen, RM; Ernst, M; Jons, PH; Matochik, JA; Pascualvaca, D; Zametkin, AJ, 1999)
"Tourette's syndrome is a neurological disorder consisting of chronic motor tics and involuntary vocalizations."	( Hogan, MB; Wilson, NW, 1999)
"Tourette's syndrome is characterized by involuntary tics and, although the underlying pathogenesis and pathophysiology of Tourette's syndrome remains unclear, it is suspected that basal ganglia structures are involved."	( Flanagan, JR; LeVasseur, AL; Munoz, DP; Riopelle, RJ, 2001)
"Tourette's syndrome is a neuropsychiatric syndrome with onset in childhood that is characterized by chronic multiple tics."	( Mink, JW, 2001)
"Tourette's disorder is a neuropsychiatric disorder characterised clinically by motor and vocal tics, which may be associated to conductual disorders such as obsessive-compulsive disorder (OCD) and attention-deficit hyperactivity disorder (ADHD)."	( García-Ruiz, PJ; Jiménez-Jiménez, FJ, 2001)
"OCD and la Tourette's syndrome are associated with left hemispheric chemical dominance."	( Kurup, PA; Kurup, RK, 2002)
"A case of Tourette's syndrome is presented in a thirteen-year-old boy with obsessive-compulsive symptoms including self-mutilation of the upper lip."	( Horie, N; Kaneko, T; Kato, T; Nasu, D; Shimoyama, T, 2003)
"Tourette's syndrome is characterized by simple, involuntary muscle contractions and/or more complex movements or stereotyped behaviors, including vocalizations."	( Cath, DC; Groenewegen, HJ; van den Heuvel, OA; Veltman, DJ; Voorn, P, 2003)
"Gilles de la Tourette's syndrome is a chronic neuropsychiatric disorder with an early childhood onset featuring mainly motor and vocal tics."	( Kocamanoglu, S; Sener, EB; Tur, A; Ustun, E, 2006)
"The treatment of Tourette's syndrome is a challenge."	( Müller-Vahl, KR, 2007)
"Tourette's syndrome is a relatively common biological genetic disorder with a broad spectrum of neurobehavioural manifestations."	( Arpaci, B; Copur, M; Demir, T; Narin, H, 2007)
"Tourette's syndrome is characterised by motor and vocal tics as well as a high level of impulsivity and emotional dysregulation."	( Habel, U; Kellermann, T; Kircher, T; Neuner, I; Schneider, F; Shah, JN; Stöcker, T, 2010)
"Gilles de la Tourette syndrome is a clinically heterogeneous disorder with poor known pathophysiology."	( Benali, H; Hartmann, A; Lehéricy, S; Malherbe, C; Messé, A; Pélégrini-Issac, M; Vidailhet, M; Worbe, Y, 2012)
"Gilles de la Tourette syndrome is a hereditary, neuropsychiatric movement disorder with reported abnormalities in the neurotransmission of dopamine and γ-aminobutyric acid (GABA)."	( Anwander, A; García-García, I; Gerasch, S; Kanaan, AS; Lampe, L; Möller, HE; Müller-Vahl, K; Near, J; Pampel, A, 2017)
"Gilles de la Tourette syndrome is a multifaceted neurodevelopmental disorder characterized by multiple motor and vocal tics."	( Bäumer, T; Beste, C; Conte, G; Kleimaker, M; Münchau, A; Onken, R; Takacs, A; Verrel, J, 2020)

Excerpt	Reference
"The management of Tourette's syndrome has become more effective with the availability of at least two psychoactive drugs, haloperidol and pimozide."	( Baird, PA; Connolly, JE; Freeman, RD, 1984)
"Tourette's disorder has long been regarded as a disorder of involuntary movement."	( Chang, HL; Hsu, YP; Ko, NC; Ray Li, CS; Wang, HS, 2006)

Excerpt	Reference
"The authors treated two children with Gilles de la Tourette's disease and one child with a probable combination of Gilles de la Tourette's disease and minimal brain dysfunction with methylphenidate, which resulted in exacerbation of symptoms."	( Fras, I; Karlavage, J, 1977)
"Three patients suffering from Gilles de la Tourette Syndrome were initially treated with haloperidol."	( Erickson, HM; Goggin, JE; Messiha, FS, 1977)
"This longitudinal, blind study of Gilles de la Tourette's disease in a 44 year old male patient who was nonresponsive to Haloperidol therapy indicates that dopamine excretion is related to clinical response."	( Knopp, W; Messiha, FS, 1976)
"Gilles de la Tourette's syndrome, a combination of multiple chronic tics and vocalizations, usually first occurring during childhood, is described in its history, symptomatology, genetics, etiology and therapy."	( Dressler, D; Schauenburg, H, 1992)
"A 25-year-old man with a history of Tourette's syndrome presented for treatment of OCD symptoms."	( Charney, DS; Delgado, PL; Goodman, WK; Heninger, GR; Price, LH, 1990)
"Nine patients with mild Tourette's syndrome completed a cross-over, placebo-controlled study of clonidine administered transdermally."	( Angell, R; Conant-Norville, D; Gancher, S, 1990)
"A 7-year-old boy with Tourette's disorder, atypical pervasive developmental disorder, borderline mental retardation, and a history of self-injurious behavior was treated for 21 months with clonidine transdermal patches at doses ranging from 0."	( Dillon, JE, 1990)
"A total of 150 patients with Tourette's syndrome were treated by different neurotropic drugs."	( Pushkov, VV, 1986)
"In pharmacological treatment of Gilles de la Tourette's syndrome neuroleptic (antipsychotic) drugs have been the most effective."	( Fog, R; Regeur, L, 1986)
"We describe two patients with Gilles de la Tourette's syndrome (TS) who developed tardive dystonia after treatment with neuroleptics."	( Jankovic, J; Singh, SK, 1988)
"A case is reported of a boy with Tourette's syndrome whose panic attacks were successfully treated with imipramine."	( Sverd, J, 1988)
"Successful treatment of Tourette's syndrome in a young man seemed to precipitate anorexia nervosa."	( Annibali, JA; Kales, JD; Tan, TL, 1986)
"Therapy for Tourette's syndrome with tricyclic antidepressants has had varied results."	( Biederman, J; Hoge, SK, 1986)
"Of the 65 patients with Gilles de la Tourette's syndrome, 59 were treated with pimozide alone or in combination with tetrabenazine or clonidine."	( Fog, R; Pakkenberg, B; Pakkenberg, H; Regeur, L, 1986)
"Two patients with Tourette's disorder were treated with calcium antagonists."	( Bronheim, S; Lavenstein, B; Licamele, WL; O'Leary, J; Walsh, TL, 1986)
"Because patients with Tourette's syndrome have been reported to have increased red blood cell choline levels, choline levels were examined in relation to treatment response."	( Hanin, I; Kopp, U; Merikangas, JR; Merikangas, KR, 1985)
"Thirteen patients with Gilles de la Tourette's syndrome were treated with clonidine (0."	( Cohen, DJ; Detlor, J; Harcherik, DF; Leckman, JF; Ort, S; Shaywitz, BA, 1985)
"for the treatment of Tourette's syndrome (TS)."	( Colvin, CL; Tankanow, RM, 1985)
"Early signs of Tourette's syndrome may be difficult to distinguish from hyperactive and attention disordered symptoms, leading the clinician to consider, treatment with stimulants."	( Cohen, DJ; Detlor, J; Kremenitzer, MW; Lowe, TL; Shaywitz, BA, 1982)
"A 25-year-old woman with Gilles de la Tourette's disease was successfully treated with clonidine (an inhibitor of noradrenaline release)."	( Acosta, E; Arocha, L; Gómez, F; Lechin, F; van der Dijs, B, 1982)
"The neurological disorder Gilles de la Tourette syndrome is most often treated with the receptor blocker haloperidol, which also produces multiple side-effects, including the risk for tardive dyskinesia."	( Ang, L; Borison, RL; Davis, JM; Diamond, BI; Hamilton, WJ, 1983)
"Five patients with Tourette's syndrome were administered a mean dose of 512 mg/kg per day of oral lecithin."	( Moldofsky, H; Sandor, P, 1983)
"A 7-year-old boy with multiple tic or Gilles de la Tourette's disease was treated with haloperidol."	( Holtzman, D; Mizrahi, EM; Tharp, B, 1980)
"This suggests that symptoms of Gilles de la Tourette syndrome which appear after withdrawal of chronic neuroleptic therapy may be due to transient hypersensitivity of dopamine receptor sites."	( Singer, WD, 1981)
"Fifteen patients with Tourette's disorder developed school and work avoidance syndromes when treated with low doses (mean 2."	( Cohen, DJ; Detlor, J; Mikkelsen, EJ, 1981)
"Early signs of Tourette's syndrome may be difficult to distinguish from hyperactive and attention disordered symptoms, leading the clinician to consider treatment with stimulants."	( Cohen, DJ; Detlor, J; Kremenitzer, MW; Lowe, TL; Shaywitz, BA, 1982)
"Because in many patients with Tourette's syndrome (TS) the ADHD symptoms are the major source of disability, alternative nonstimulant treatments are needed."	( Biederman, J; Spencer, T; Steingard, R; Wilens, T, 1993)
"Thirty-eight patients with Tourette's syndrome volunteered to take risperidone for treatment of their tics."	( Bruun, RD; Budman, CL, 1996)
"Medications used in the treatment of Tourette's syndrome are thought to modulate the functioning of these neural systems."	( Peterson, BS, 1996)
"Two patients suffering from Tourette's Syndrome who had developed episodes of continual motor tics that lasted from minutes to hours, were non-suppressible and intruded into normal functioning, were treated with an increase in the dose of haloperidol, in one case with the addition of clonazepam."	( Chee, KY; Sachdev, P; Wilson, A, 1996)
"The treatment of Tourette's syndrome (TS) is often unsatisfactory."	( Dursun, SM; Reveley, MA, 1997)
"We enrolled 450 patients with tics/Tourette's syndrome to be treated with baclofen/botolinum toxin type A for their symptoms."	( Awaad, Y, 1999)
"The treatment of the Gilles de la Tourette syndrome has evolved from case reports, clinical experience and more recently blinded trials usually in small numbers of patients."	( Robertson, MM; Stern, JS, 2000)
"The treatment of Tourette's disorder with classical neuroleptics is limited by their side effects."	( Bruggeman, R; Buitelaar, JK; Gericke, GS; Hawkridge, SM; Temlett, JA; van der Linden, C, 2001)
"Early differential diagnosis between Tourette's syndrome and chronic tic disorder is difficult but important because both the outcome and the treatment of these two childhood-onset diseases are distinct."	( Chang, YC; Chiu, NT; Huang, CC; Lee, BF; Wang, ST, 2001)
"Two children with Tourette's syndrome and comorbid disorders were treated with quetiapine, an atypical antipsychotic successfully used in patients with psychoses and schizophrenia with low incidence of extrapyramidal side effects."	( Fenning, PA; Párraga, HC; Párraga, MI; Woodward, RL, 2001)
"Seventy patients with DSM-IV Tourette's disorder were treated with either transdermal nicotine (7 mg/24 hours) or placebo patches in a 33-day, randomized, double-blind study."	( McConville, B; Philipp, MK; Sanberg, PR; Shytle, RD; Silver, AA; Wilkinson, BJ, 2001)
"A patient with Gilles de la Tourette syndrome treated with haloperidol, ingested once daily after awakening from sleep, exhibited an irregular sleep-wake pattern with a free-running component of approximately 48 h."	( Ayalon, L; Dagan, Y; Hermesh, H, 2002)
"A 21-year-old man with Tourette's syndrome, pedophilia, Asperger's syndrome, and multiple sclerosis experienced seizures after receiving therapy with interferon beta-1a."	( Dubisar, BM; Farrar, CD; Khan, R; Stoner, SC, 2002)
"Seven subjects were diagnosed with Tourette's Disorder and 8 subjects with chronic tic disorder, and all subjects were administered risperidone without hospitalization."	( Cho, SC; Hwang, JW; Kim, BN; Lee, CB; Shin, MS, 2005)
"The treatment of the Gilles de la Tourette syndrome (GTS) is often challenging."	( Bubl, E; Perlov, E; Tebartz Van Elst, L, 2006)
"The treatment of Tourette's syndrome is a challenge."	( Müller-Vahl, KR, 2007)
"Twelve patients aged 8-18 years with Tourette's syndrome (diagnosed according to Diagnostic and Statistical Manual IV criteria) who were receiving quetiapine therapy and had no diagnosis of epilepsy, major depression or psychotic disorder, were included in the study."	( Arpaci, B; Copur, M; Demir, T; Narin, H, 2007)
"We reported a case with late-onset Tourette's disorder (TD) in whom motor tics and emotional instability improved with 18 mg/day of aripiprazole treatment."	( Hayashi, K; Hori, H; Ikenouchi-Sugita, A; Nakamura, J; Ueda, N; Umene-Nakano, W; Yoshimura, R, 2009)
"Children with Tourette's syndrome (TS) have a poor treatment compliance due to side effects and inconvenient administration of oral drugs."	( Gao, XM; Guo, XY; Jiao, FY; Kang, H; Zhang, YF, 2009)
"Many patients with Tourette's syndrome experience impairing tic symptoms despite use of available evidence-based treatments."	( Bloch, MH; Johnson, JA; Landeros-Weisenberger, A; Leckman, JF, 2021)

Timeframe	Studies, This Condition (%)	All Conditions %
pre-1990	469 (36.78)	23.3326
1990's	266 (20.86)	12.5806
2000's	276 (21.65)	18.1394
2010's	207 (16.24)	28.8240
2020's	57 (4.47)	9.53

Drug	Relationship Strength	Studies	Trials
gamma-aminobutyric acid	medium	31	1
5-hydroxytryptophan	low	4	0
adenine	low	1	0
choline	low	11	0
chlorine	low	1	0
salicylic acid	medium	3	1
bupropion	low	2	0
3,4-dihydroxyphenylacetic acid	low	3	0
creatine	low	2	0
glycine	low	1	0
histamine	low	11	0
hydrogen	low	1	0
indoleacetic acid	low	1	0
iodine	low	1	0
dihydroxyphenylalanine	low	3	0
kynurenine	low	3	0
inositol	low	1	0
melatonin	medium	3	1
phenylacetic acid	low	1	0
phenethylamine	low	4	0
pteridines	low	1	0
pyridoxine	low	2	0
tryptamine	low	2	0
uric acid	low	2	0
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	low	1	0
sk&f 82958	low	1	0
4-iodo-2,5-dimethoxyphenylisopropylamine	low	6	0
normetanephrine	low	3	0
sk&f-38393	medium	2	1
vanilmandelic acid	low	1	0
pk 11195	low	1	0
1-(3-chlorophenyl)piperazine	medium	1	1
3-methoxytyramine	low	1	0
homovanillic acid	medium	32	1
phenytoin	low	1	0
hydroxyindoleacetic acid	medium	19	1
amantadine	medium	5	2
dan 2163	low	5	0
amitriptyline	low	2	0
amobarbital	low	1	0
aspirin	low	1	0
baclofen	medium	2	2
benserazide	low	1	0
berberine	medium	1	1
biperiden	low	2	0
buspirone	low	1	0
caffeine	low	1	0
verapamil	low	2	0
carbamazepine	low	6	0
celecoxib	low	1	0
chlordiazepoxide	low	1	0
chlorpromazine	medium	19	1
ciprofloxacin	low	1	0
citalopram	medium	4	1
clomipramine	medium	27	1
clonazepam	low	12	0
clonidine	medium	113	19
cyproheptadine	low	1	0
debrisoquin	low	4	0
desipramine	medium	10	2
amphetamine	medium	15	2
diazepam	medium	4	1
valproic acid	low	5	0
p-chloroamphetamine	low	1	0
donepezil	low	4	0
doxepin	low	1	0
droperidol	low	1	0
fenfluramine	low	1	0
fluphenazine	medium	11	4
flumazenil	low	1	0
fluoxetine	medium	25	6
flutamide	medium	2	2
guanfacine	low	12	0
haloperidol	medium	300	27
imipramine	low	10	0
isocarboxazid	low	1	0
ketanserin	medium	3	1
lamotrigine	low	5	0
lansoprazole	low	1	0
lorazepam	low	2	0
loxapine	low	2	0
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one	low	1	0
mecamylamine	medium	8	3
mesoridazine	low	1	0
metformin	low	1	0
methadone	low	3	0
methylphenidate	medium	46	8
metoclopramide	medium	6	3
mitoxantrone	low	1	0
nefazodone	low	1	0
nifedipine	medium	4	1
nortriptyline	low	2	0
ofloxacin	low	1	0
ondansetron	medium	3	2
orphenadrine	medium	1	1
oxidopamine	low	1	0
oxybutynin	medium	1	1
palmidrol	medium	1	1
pemoline	low	10	0
perphenazine	low	3	0
phenindione	low	1	0
phenobarbital	low	2	0
piracetam	medium	6	4
pirenzepine	medium	10	4
piribedil	medium	3	1
primidone	low	1	0
probenecid	low	2	0
procyclidine	low	1	0
promethazine	low	2	0
propranolol	medium	7	1
riluzole	medium	2	1
risperidone	medium	49	7
ropinirole	medium	1	1
spiperone	low	1	0
sulpiride	low	15	0
talipexole	medium	1	1
thiethylperazine	low	1	0
thioridazine	low	9	0
thiothixene	low	1	0
trifluoperazine	medium	7	2
trifluperidol	low	1	0
triflupromazine	low	1	0
trihexyphenidyl	low	5	0
trimipramine	low	1	0
vigabatrin	low	1	0
corticosterone	low	1	0
prednisolone	low	2	0
lysergic acid diethylamide	low	1	0
reserpine	low	3	0
thyroxine	low	3	0
dextroamphetamine	medium	22	3
prednisone	low	1	0
pentylenetetrazole	low	1	0
triiodothyronine	low	1	0
serine	medium	1	1
aspartic acid	low	1	0
glutamine	low	6	0
physostigmine	medium	6	1
apomorphine	medium	9	1
tetrabenazine	medium	27	5
carbostyril	medium	38	7
levodopa	medium	22	3
tyrosine	low	3	0
methionine	low	2	0
phenylalanine	low	2	0
cycloserine	low	1	0
histidine	low	1	0
valine	low	6	0
tryptophan	medium	17	1
propane	low	1	0
methylprednisolone	low	2	0
quinoxalines	low	1	0
pyrrolidonecarboxylic acid	medium	1	1
propionitrile	low	1	0
deanol	medium	3	1
3,3'-iminodipropionitrile	low	6	0
ergotamine	low	1	0
1-naphthylamine	medium	4	1
yohimbine	low	1	0
isoxazoles	low	7	0
thiazoles	medium	12	4
citrulline	low	1	0
cyproterone acetate	low	1	0
dextropropoxyphene	medium	1	1
bicuculline	low	2	0
indophenol	low	3	0
methoxyhydroxyphenylglycol	medium	18	1
malondialdehyde	low	1	0
lithium carbonate	medium	6	1
acetylcysteine	medium	1	1
erythromycin	low	2	0
4-amino-3-phenylbutyric acid	low	1	0
pyrithioxin	low	1	0
s,n,n'-tripropylthiocarbamate	medium	13	3
dronabinol	medium	19	6
methionine sulfoximine	low	1	0
pimozide	medium	82	16
benperidol	low	1	0
flupenthixol	medium	1	1
fluorine	low	1	0
calcium pyrophosphate	low	1	0
trolamine salicylate	low	1	0
selegiline	medium	6	1
pregnanolone	low	3	0
4-methoxyamphetamine	low	1	0
glutamic acid	low	13	0
torpedo	low	1	0
penfluridol	low	1	0
tramadol	low	2	0
substance p	low	2	0
diltiazem	low	1	0
paroxetine	medium	4	1
progabide	low	1	0
pergolide	medium	5	3
fomesafen	medium	5	2
haloperidol decanoate	low	3	0
quinpirole	low	1	0
atomoxetine hydrochloride	medium	12	2
spiradoline	medium	2	1
finasteride	medium	4	1
naxagolide	low	2	0
aripiprazole	medium	57	8
ziprasidone	medium	12	4
glucose, (beta-d)-isomer	low	7	0
n-acetylaspartic acid	low	1	0
cephalosporin c	low	1	0
triazoles	low	1	0
fluorodeoxyglucose f18	low	8	0
sertraline	medium	11	1
tianeptine	low	1	0
clarithromycin	low	2	0
nicotine	medium	30	5
phenylacetylglutamine	low	1	0
vitamin b 6	medium	4	3
(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane	low	1	0
ecopipam	medium	4	2
3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide	low	3	0
dynorphin (1-8)	low	2	0
deoxyglucose	low	5	0
gastrodin	low	6	0
3-n-methylspiperone	low	1	0
pramipexole	medium	1	1
ro 22-1319	medium	3	2
tryptophan methyl ester	low	1	0
ro 8-0576	low	1	0
dihydrotetrabenazine	low	3	0
blonanserin	low	1	0
dexmethylphenidate hydrochloride	medium	1	1
rhodioloside	low	1	0
6-hydroxytryptamine	low	1	0
asenapine	low	1	0
atropine	low	2	0
1-testosterone	low	1	0
benzofurans	low	1	0
ritonavir	low	1	0
oxytocin	low	2	0
theanine	medium	1	1
inositol 1,4,5-trisphosphate	low	1	0
inositol 3-phosphate	low	3	0
pentazocine	low	1	0
diprenorphine	low	1	0
tretinoin	low	1	0
cocaine	low	11	0
zithromax	low	1	0
aphidicolin	low	2	0
enkephalin, leucine	low	1	0
riboflavin	low	1	0
cannabidiol	low	5	0
buprenorphine	low	1	0
arginine vasopressin	low	1	0
leuprolide	low	1	0
alpha-methyltryptophan, (l)-isomer	low	1	0
cotinine	medium	1	1
flunarizine	medium	1	1
benztropine	medium	9	4
enclomiphene	low	3	0
D-fructopyranose	medium	5	1
digoxin	low	1	0
rhyncophylline	low	3	0
lithium	medium	17	3
altanserin	low	1	0
raclopride	medium	6	1
sch 23390	low	1	0
2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline	low	1	0
6-cyano-7-nitroquinoxaline-2,3-dione	low	1	0
17-ketosteroids	low	1	0
am 281	low	1	0
myelin basic protein	low	2	0
humulene	low	6	0
anandamide	low	1	0
codeine	low	4	0
levetiracetam	medium	6	4
naloxone	medium	14	1
oxycodone	low	3	0
topiramate	medium	6	1
morphine	low	2	0
deamino arginine vasopressin	low	1	0
mdl 100907	low	1	0
fluvoxamine	medium	11	3
levorphanol	low	1	0
naltrexone	medium	7	1
indinavir sulfate	low	1	0
methylazoxymethanol acetate	low	1	0
cysteine	low	2	0
heroin	low	1	0
pregabalin	low	1	0
tiapridex	medium	2	1
dizocilpine maleate	low	1	0
antimycin a	low	1	0
dolichols	low	1	0
tiapamil hydrochloride	medium	9	3
stepholidine	medium	1	1
delta9-tetrahydrocannabinol hemisuccinate	low	1	0
paliperidone palmitate	low	3	0
flb 457	low	1	0
pitolisant	low	1	0
g(m1) ganglioside	low	1	0
n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide	low	1	0
2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane	low	1	0
technetium tc 99m exametazime	medium	7	1
scopolamine hydrobromide	medium	3	1
acid phosphatase	low	1	0
jaw	low	1	0
dynorphins	medium	6	1
beta-endorphin	low	1	0
phosphatidylcholines	low	8	0
ro13-9904	low	1	0
valbenazine	low	3	0
quetiapine fumarate	medium	15	2
neurotensin	low	1	0
gw 1000	medium	4	1
piperidines	low	12	0
interleukin-8	low	1	0
minocycline	low	1	0
warfarin	low	1	0
phenprocoumon	low	1	0
daptomycin	low	1	0
exudates	low	1	0
acyclovir	low	1	0
guanine	low	2	0
inosine	medium	1	1
neopterin	low	2	0
clozapine	medium	13	1
olanzapine	medium	17	6
eye	low	1	0
carbidopa	medium	3	1
ego	low	4	0
technetium tc 99m bicisate	low	2	0

Protein Targets (1,712)

Protein	Potency Measurements	Inhibition Measurements	Activation Measurements	Drugs
Sodium-dependent serotonin transporter	0	66	8	75
Sodium-dependent dopamine transporter	0	51	6	57
Chain A, TYROSYL-DNA PHOSPHODIESTERASE	27	0	0	27
5-hydroxytryptamine receptor 3E	0	8	2	11
acetylcholinesterase	35	0	0	35
TDP1 protein	95	0	0	95
cytochrome P450 2D6	64	0	0	64
v-jun sarcoma virus 17 oncogene homolog (avian)	38	0	0	38
cytochrome P450 2D6 isoform 1	43	0	0	43
cellular tumor antigen p53 isoform a	20	0	0	20
cytochrome P450 2C19 precursor	26	0	0	26
cytochrome P450 2C9 precursor	24	0	0	24
thyroid hormone receptor beta isoform a	22	0	0	22
thyroid hormone receptor beta isoform 2	68	0	0	68
huntingtin isoform 2	13	0	0	13
peripheral myelin protein 22	46	0	0	46
cytochrome P450 3A4 isoform 1	46	0	0	46
muscarinic acetylcholine receptor M1	47	0	0	47
Gamma-aminobutyric acid receptor subunit pi	46	20	4	70
Polyunsaturated fatty acid lipoxygenase ALOX15B	26	0	0	26
ATP-binding cassette sub-family C member 3	0	73	0	73
Multidrug resistance-associated protein 4	0	73	0	73
5-hydroxytryptamine receptor 3B	0	8	2	11
Bile salt export pump	0	109	0	109
Beta-1 adrenergic receptor	0	6	1	7
5-hydroxytryptamine receptor 1A	0	27	14	41
5-hydroxytryptamine receptor 2C	0	45	8	53
D(2) dopamine receptor	0	83	13	106
5-hydroxytryptamine receptor 2A	0	52	11	63
Gamma-aminobutyric acid receptor subunit beta-1	46	20	4	70
Alpha-1B adrenergic receptor	0	49	5	54
Gamma-aminobutyric acid receptor subunit delta	46	20	4	70
Gamma-aminobutyric acid receptor subunit gamma-2	46	20	6	72
D	0	39	0	42
5-hydroxytryptamine receptor 1A	0	70	8	79
Gamma-aminobutyric acid receptor subunit alpha-5	46	20	4	70
Gamma-aminobutyric acid receptor subunit alpha-3	46	20	4	70
Gamma-aminobutyric acid receptor subunit gamma-1	46	20	4	70
Gamma-aminobutyric acid receptor subunit alpha-2	46	20	4	70
Alpha-1D adrenergic receptor	0	38	5	43
5-hydroxytryptamine receptor 2A	0	84	10	99
5-hydroxytryptamine receptor 2C	0	79	5	85
Gamma-aminobutyric acid receptor subunit alpha-4	46	20	4	70
Gamma-aminobutyric acid receptor subunit gamma-3	46	20	4	70
5-hydroxytryptamine receptor 1B	0	55	5	60
5-hydroxytryptamine receptor 1D	0	21	5	26
Gamma-aminobutyric acid receptor subunit alpha-6	46	20	4	70
5-hydroxytryptamine receptor 1F	0	21	5	26
5-hydroxytryptamine receptor 5A	0	1	0	1
5-hydroxytryptamine receptor 2B	0	43	9	52
5-hydroxytryptamine receptor 7	0	24	6	30
5-hydroxytryptamine receptor 7	0	23	1	24
Alpha-1B adrenergic receptor	0	12	2	15
Glutamate receptor ionotropic, NMDA 1	0	18	3	27
5-hydroxytryptamine receptor 2B	0	75	3	79
Alpha-1A adrenergic receptor	0	60	6	66
5-hydroxytryptamine receptor 3A	0	11	2	14
Histamine H2 receptor	42	6	1	58
5-hydroxytryptamine receptor 6	0	55	1	58
Beta-2 adrenergic receptor	0	2	0	2
D(2) dopamine receptor	0	70	11	86
Gamma-aminobutyric acid receptor subunit alpha-1	46	22	6	74
Gamma-aminobutyric acid receptor subunit beta-3	46	20	4	70
Gamma-aminobutyric acid receptor subunit beta-2	46	20	6	72
Glutamate receptor ionotropic, NMDA 2A	0	18	3	27
Glutamate receptor ionotropic, NMDA 2B	0	19	3	28
Glutamate receptor ionotropic, NMDA 2C	0	19	3	28
Glutamate receptor ionotropic, NMDA 2D	0	18	3	27
5-hydroxytryptamine receptor 3D	0	8	2	11
Glutamate receptor ionotropic, NMDA 3B	0	18	3	27
5-hydroxytryptamine receptor 3C	0	8	2	11
GABA theta subunit	46	20	4	70
Canalicular multispecific organic anion transporter 1	0	74	0	74
Gamma-aminobutyric acid receptor subunit epsilon	46	20	4	70
Glutamate receptor ionotropic, NMDA 3A	0	18	3	27
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE	35	0	0	35
Chain A, HADH2 protein	29	0	0	29
Chain B, HADH2 protein	29	0	0	29
RAR-related orphan receptor gamma	59	0	0	59
GLI family zinc finger 3	62	0	0	62
AR protein	82	0	0	82
aldehyde dehydrogenase 1 family, member A1	43	0	0	43
thyroid stimulating hormone receptor	43	0	0	43
estrogen receptor 2 (ER beta)	31	0	0	31
nuclear receptor subfamily 1, group I, member 3	52	0	0	52
progesterone receptor	42	0	0	42
glucocorticoid receptor [Homo sapiens]	62	0	0	62
retinoic acid nuclear receptor alpha variant 1	54	0	0	54
estrogen-related nuclear receptor alpha	67	0	0	67
pregnane X nuclear receptor	56	0	0	56
estrogen nuclear receptor alpha	88	0	0	88
aryl hydrocarbon receptor	31	0	0	31
thyroid stimulating hormone receptor	38	0	0	38
activating transcription factor 6	22	0	0	22
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a	28	0	0	28
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1	17	0	0	17
nuclear factor erythroid 2-related factor 2 isoform 1	55	0	0	55
Voltage-dependent calcium channel gamma-2 subunit	31	0	0	31
Glutamate receptor 2	33	6	4	45
Kelch-like ECH-associated protein 1	0	0	1	1
Histone acetyltransferase KAT8	0	1	0	1
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1	0	1	0	1
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1	0	1	0	1
Chain A, 2-oxoglutarate Oxygenase	28	0	0	28
Chain A, Cruzipain	9	0	0	9
Chain A, Methyltransferase Wbdd	0	1	0	1
thioredoxin reductase	60	0	0	60
15-lipoxygenase, partial	20	0	0	20
ATAD5 protein, partial	39	0	0	39
NFKB1 protein, partial	23	0	0	23
Thrombopoietin	18	0	0	18
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)	21	0	0	21
regulator of G-protein signaling 4	56	0	0	56
EWS/FLI fusion protein	42	0	0	42
67.9K protein	19	0	0	19
Parkin	8	0	0	8
euchromatic histone-lysine N-methyltransferase 2	106	0	0	106
chromobox protein homolog 1	60	0	0	60
flap endonuclease 1	28	0	0	28
serine/threonine-protein kinase mTOR isoform 1	27	0	0	27
survival motor neuron protein isoform d	25	0	0	25
M-phase phosphoprotein 8	26	0	0	26
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	0	1	0	2
cGMP-dependent 3',5'-cyclic phosphodiesterase	0	1	0	1
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	0	1	0	1
Serine/threonine-protein kinase PLK4	0	1	0	1
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	0	1	0	1
Bromodomain-containing protein 4	0	1	0	1
5-hydroxytryptamine receptor 4	0	62	0	62
cGMP-specific 3',5'-cyclic phosphodiesterase	0	3	0	3
Integrin beta-3	16	3	1	20
Cytochrome P450 1A2	0	12	2	15
Integrin alpha-IIb	16	3	1	20
Neuronal acetylcholine receptor subunit alpha-4	3	12	5	21
Serine/threonine-protein kinase pim-1	0	1	0	1
Neuronal acetylcholine receptor subunit beta-2	3	11	5	20
Casein kinase II subunit alpha'	0	2	0	2
Proteinase-activated receptor 1	0	1	1	3
Bromodomain-containing protein 2	0	1	0	1
Phosphatidylinositol 3-kinase regulatory subunit alpha	0	1	0	2
Sodium-dependent serotonin transporter	0	21	4	26
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	1	0	1
Type-1 angiotensin II receptor	0	1	0	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	2	0	3
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	0	1	0	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	0	1	0	3
Serine/threonine-protein kinase mTOR	0	2	0	2
Serine/threonine-protein kinase mTOR	0	1	0	1
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	0	2	0	3
Glycogen synthase kinase-3 beta	0	2	0	2
D(1A) dopamine receptor	19	4	0	23
Serine/threonine-protein kinase PLK1	0	2	0	2
Casein kinase II subunit beta	0	2	0	2
Casein kinase II subunit alpha	0	2	0	2
DNA-dependent protein kinase catalytic subunit	0	4	0	4
Mu-type opioid receptor	0	19	4	24
Serine-protein kinase ATM	0	2	0	2
cGMP-inhibited 3',5'-cyclic phosphodiesterase B	0	1	0	1
Serine/threonine-protein kinase ATR	0	2	0	2
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	0	1	0	1
Bromodomain-containing protein 3	0	1	0	1
Serine/threonine-protein kinase pim-3	0	1	0	1
Phosphoinositide 3-kinase regulatory subunit 5	0	1	0	1
Serine/threonine-protein kinase PLK3	0	2	0	2
Serine/threonine-protein kinase PLK2	0	1	0	1
ATP-dependent phosphofructokinase	50	0	0	50
Chain A, Putative fructose-1,6-bisphosphate aldolase	15	0	0	15
Chain A, ATP-DEPENDENT DNA HELICASE Q1	13	0	0	13
phosphopantetheinyl transferase	37	0	0	37
USP1 protein, partial	39	0	0	39
Microtubule-associated protein tau	38	0	0	38
alpha-galactosidase	7	0	0	7
vitamin D3 receptor isoform VDRA	26	0	0	26
DNA polymerase kappa isoform 1	22	0	0	22
histone acetyltransferase KAT2A isoform 1	27	0	0	27
Metabotropic glutamate receptor 6	0	2	2	5
Glutamate receptor 1	2	6	4	14
Glutamate receptor 3	2	6	4	14
Glutamate receptor 4	2	6	4	14
Glutamate receptor ionotropic, kainate 1	0	6	2	8
Adenosine receptor A1	0	11	0	17
Glutamate receptor ionotropic, kainate 1	0	5	1	6
Glutamate receptor ionotropic, kainate 2	0	6	1	7
Glutamate receptor 1	0	7	2	10
Glutamate receptor 2	0	7	2	10
Glutamate receptor 3	0	6	1	7
Glutamate receptor ionotropic, kainate 3	0	5	0	5
Glutamate receptor 4	0	7	1	9
Glutamate receptor ionotropic, kainate 4	0	5	0	5
Glutamate receptor ionotropic, kainate 2	0	5	1	6
Glutamate receptor ionotropic, kainate 3	0	4	0	4
Glutamate receptor ionotropic, kainate 5	0	5	1	6
D(4) dopamine receptor	0	35	5	47
D(3) dopamine receptor	0	71	9	89
mitogen-activated protein kinase 1	33	0	0	33
Trace amine-associated receptor 1	0	0	5	5
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, Penicillin Amidohydrolase	0	1	0	1
Chain B, Penicillin Amidohydrolase	0	1	0	1
Chain A, JmjC domain-containing histone demethylation protein 3A	17	0	0	17
Chain A, Protocatechuate 3,4-dioxygenase	0	0	1	1
Chain M, Protocatechuate 3,4-dioxygenase	0	0	1	1
Olfactory receptor class A-like protein 1	0	0	2	2
Luciferase	17	0	0	17
endonuclease IV	12	0	0	12
RGS12	1	0	0	1
GLS protein	57	0	0	57
alkaline phosphatase, intestinal	0	0	1	1
thioredoxin glutathione reductase	8	0	0	8
apical membrane antigen 1, AMA1	10	0	0	10
hypothetical protein, conserved	6	0	0	6
Bloom syndrome protein isoform 1	33	0	0	33
lysosomal alpha-glucosidase preproprotein	7	0	0	7
peripheral myelin protein 22 isoform 1	18	0	0	18
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein	0	1	0	1
intestinal alkaline phosphatase precursor	0	1	0	1
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1	1	0	0	1
DNA polymerase beta	8	0	0	8
DNA polymerase iota isoform a (long)	17	0	0	17
geminin	70	0	0	70
alkaline phosphatase, germ cell type preproprotein	0	0	1	1
POsterior Segregation	0	0	3	3
lamin isoform A-delta10	65	0	0	65
Prolyl 4-hydroxylase subunit alpha-1	0	3	0	3
Sodium-dependent noradrenaline transporter	0	65	8	73
Zinc finger protein mex-5	0	0	2	2
Gamma-aminobutyric acid type B receptor subunit 2	0	4	2	6
Gamma-aminobutyric acid type B receptor subunit 1	0	4	2	6
atrial natriuretic peptide receptor 1 precursor	13	0	0	13
5-hydroxytryptamine receptor 6	0	11	5	16
5-hydroxytryptamine receptor 2C	0	5	0	6
5-hydroxytryptamine receptor 2A	0	3	0	4
5-hydroxytryptamine receptor 5A	0	11	5	16
5-hydroxytryptamine receptor 5B	0	11	5	16
5-hydroxytryptamine receptor 3A	0	16	6	22
5-hydroxytryptamine receptor 5A	0	8	0	8
5-hydroxytryptamine receptor 4	0	13	5	19
Ataxin-2	53	0	0	53
5-hydroxytryptamine receptor 3B	0	16	6	22
glucocerebrosidase	11	0	0	11
lethal factor (plasmid)	27	0	0	27
Inositol monophosphatase 1	20	0	0	20
dopamine D1 receptor	14	0	0	14
pregnane X receptor	11	0	0	11
retinoid X nuclear receptor alpha	41	0	0	41
farnesoid X nuclear receptor	32	0	0	32
vitamin D (1,25- dihydroxyvitamin D3) receptor	33	0	0	33
arylsulfatase A	48	0	0	48
D(1A) dopamine receptor	51	0	0	51
heat shock protein beta-1	19	0	0	19
Histone deacetylase 3	0	5	0	5
Solute carrier family 22 member 6	0	4	0	5
Histone deacetylase 4	0	5	0	5
Guanine nucleotide-binding protein G	4	0	0	4
Histone deacetylase 1	0	5	0	5
Histone deacetylase 7	0	5	0	5
Histone deacetylase 2	0	5	0	5
Polyamine deacetylase HDAC10	0	5	0	5
Histone deacetylase 11	0	5	0	5
Histone deacetylase 8	0	5	0	5
Histone deacetylase 6	0	5	0	5
Histone deacetylase 9	0	5	0	5
Histone deacetylase 5	0	5	0	5
Chain E, Purine nucleoside phosphorylase	0	1	0	1
Chain A, Ferritin light chain	17	0	0	17
Thymidine kinase	0	1	0	1
Smad3	20	0	0	20
Histone H2A.x	14	0	0	14
hemoglobin subunit beta	2	0	0	2
ubiquitin carboxyl-terminal hydrolase 2 isoform a	11	0	0	11
Solute carrier family 22 member 1	0	35	0	41
Bile salt export pump	0	19	0	19
Purine nucleoside phosphorylase	0	3	0	4
Thymidine kinase, cytosolic	0	0	0	1
POU domain, class 2, transcription factor 2	0	0	0	1
Cytochrome P450 2C9	0	31	1	33
Cytochrome P450 2J2	0	23	0	24
Disintegrin and metalloproteinase domain-containing protein 17	9	0	0	9
Purine nucleoside phosphorylase	0	0	1	1
Solute carrier family 22 member 6	0	3	0	5
Thymidine kinase	0	1	0	1
Solute carrier family 22 member 8	0	4	0	5
Thymidine kinase	0	1	0	1
Chain A, MTA/SAH nucleosidase	0	1	0	1
Chain A, Ribosome-inactivating protein alpha-trichosanthin	0	0	1	1
Chain A, Ricin A chain	0	0	1	1
Chain A, Ribosome-inactivating protein 3	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
Chain A, Phenylethanolamine N-methyltransferase	0	0	1	1
cytochrome P450 family 3 subfamily A polypeptide 4	56	0	0	56
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a	39	0	0	39
nuclear factor erythroid 2-related factor 2 isoform 2	23	0	0	23
importin subunit beta-1 isoform 1	8	0	0	8
snurportin-1	8	0	0	8
tumor susceptibility gene 101 protein	1	0	0	1
GTP-binding nuclear protein Ran isoform 1	4	0	0	4
Cyclin-dependent kinase 1	0	1	0	1
Heat shock protein HSP 90-beta	0	1	0	1
Xanthine dehydrogenase/oxidase	0	1	0	1
TAR DNA-binding protein 43	11	1	0	12
Protein mono-ADP-ribosyltransferase PARP15	0	2	0	2
Leucine-rich repeat serine/threonine-protein kinase 2	0	2	0	2
ATPase family AAA domain-containing protein 5	24	0	0	24
Glutamate receptor ionotropic, NMDA 2D	0	7	0	7
Glutamate receptor ionotropic, NMDA 3B	0	7	0	7
Glutamate receptor 1	0	1	1	2
Glutamate receptor 2	0	1	0	1
Excitatory amino acid transporter 1	0	4	0	5
Excitatory amino acid transporter 2	0	4	0	5
Excitatory amino acid transporter 3	0	4	0	5
Glutamate receptor ionotropic, NMDA 1	0	7	0	7
Glutamate receptor ionotropic, NMDA 2A	0	7	0	7
Glutamate receptor ionotropic, NMDA 2B	0	7	0	7
Glutamate receptor ionotropic, NMDA 2C	0	7	0	7
Glutamate receptor ionotropic, kainate 4	0	1	0	1
Glutamate receptor ionotropic, kainate 5	0	2	0	2
Glutamate receptor ionotropic, NMDA 3A	0	7	0	7
Glutamate receptor 4	0	1	0	1
Glutamate receptor 3	0	1	0	1
nuclear receptor ROR-gamma isoform 1	28	0	0	28
Cannabinoid receptor 1	0	6	2	8
Cannabinoid receptor 1	0	8	1	12
Cannabinoid receptor 2	0	6	2	11
signal transducer and activator of transcription 6, interleukin-4 induced	1	0	0	1
putative alpha-glucosidase	1	0	0	1
Solute carrier family 22 member 2	0	14	0	17
Matrix protein 2	0	1	1	2
Matrix protein 2	0	1	2	3
Spike glycoprotein	45	3	7	55
Solute carrier family 22 member 1	0	13	0	17
Multidrug and toxin extrusion protein 1	0	14	0	14
Solute carrier family 22 member 2	0	9	0	12
atrial natriuretic peptide receptor 2 precursor	21	0	0	21
Voltage-dependent L-type calcium channel subunit alpha-1F	0	19	0	19
Albumin	0	0	12	12
High affinity nerve growth factor receptor	0	1	2	3
Aldo-keto reductase family 1 member B1	0	47	0	47
Muscarinic acetylcholine receptor M2	0	49	4	58
Muscarinic acetylcholine receptor M4	0	53	2	58
Muscarinic acetylcholine receptor M1	0	23	1	26
Muscarinic acetylcholine receptor M3	0	20	1	23
Muscarinic acetylcholine receptor M4	0	20	1	23
Muscarinic acetylcholine receptor M5	0	19	1	22
Muscarinic acetylcholine receptor M5	0	50	1	54
Alpha-2A adrenergic receptor	0	62	6	69
Muscarinic acetylcholine receptor M2	0	23	2	28
Muscarinic acetylcholine receptor M1	0	56	5	67
Angiotensin-converting enzyme	0	36	0	36
Alpha-2B adrenergic receptor	0	59	2	62
Alpha-2C adrenergic receptor	0	55	5	61
Muscarinic acetylcholine receptor M3	0	52	3	58
D(1A) dopamine receptor	0	52	8	65
D(1B) dopamine receptor	0	17	1	22
UDP-glucuronosyltransferase 1A4	0	1	0	9
Histamine H2 receptor	0	33	4	37
Alpha-1D adrenergic receptor	0	52	2	55
Histamine H1 receptor	0	15	1	16
Histamine H1 receptor	0	52	7	62
Sodium channel protein type 1 subunit alpha	0	9	0	9
Sodium channel protein type 4 subunit alpha	0	10	0	13
UDP-glucuronosyltransferase 1A3	0	0	0	4
5-hydroxytryptamine receptor 7	0	21	0	21
Voltage-dependent N-type calcium channel subunit alpha-1B	0	8	0	8
Sodium channel protein type 7 subunit alpha	0	7	0	7
Voltage-dependent L-type calcium channel subunit alpha-1D	0	19	0	19
Potassium voltage-gated channel subfamily H member 2	0	76	0	77
Voltage-dependent L-type calcium channel subunit alpha-1S	0	19	0	19
Voltage-dependent L-type calcium channel subunit alpha-1C	0	21	0	22
Sodium channel protein type 5 subunit alpha	0	15	0	15
Sodium channel protein type 9 subunit alpha	0	11	0	11
Sigma non-opioid intracellular receptor 1	0	10	2	12
Nuclear receptor subfamily 3 group C member 3	0	35	0	35
Sodium channel protein type 2 subunit alpha	0	10	0	10
Sigma non-opioid intracellular receptor 1	0	56	1	57
Sodium channel protein type 3 subunit alpha	0	10	0	10
Sodium channel protein type 11 subunit alpha	0	7	0	7
Sodium channel protein type 8 subunit alpha	0	7	0	7
Histamine H3 receptor	0	14	2	17
Sodium channel protein type 10 subunit alpha	0	8	0	8
Solute carrier family 22 member 3	0	3	0	3
Phenylethanolamine N-methyltransferase	0	4	0	4
Cytochrome P450 2A6	0	9	2	11
Substance-P receptor	0	3	0	3
Cytochrome P450 2A5	0	4	0	4
Sodium-dependent dopamine transporter	0	31	2	33
Beta-2 adrenergic receptor	0	5	1	8
Sigma non-opioid intracellular receptor 1	0	13	3	16
Fatty-acid amide hydrolase 1	0	3	0	3
Fatty-acid amide hydrolase 1	0	0	0	1
Potassium channel subfamily K member 3	0	1	0	1
Fatty acid-binding protein, liver	0	3	0	3
Cannabinoid receptor 1	0	2	0	2
Cannabinoid receptor 2	0	2	1	3
Fatty-acid amide hydrolase 1	0	4	0	5
Fatty acid-binding protein 5	0	0	1	1
Corticotropin-releasing factor receptor 2	0	2	0	2
Lanosterol 14-alpha demethylase	0	2	0	2
Potassium channel subfamily K member 2	0	3	0	3
Transient receptor potential cation channel subfamily V member 1	0	1	3	5
Cannabinoid receptor 2	0	3	0	3
Transient receptor potential cation channel subfamily V member 2	0	4	1	5
DNA polymerase catalytic subunit	0	1	0	1
DNA polymerase catalytic subunit	0	1	0	1
DNA polymerase beta	0	1	0	1
DNA polymerase beta	0	1	0	1
DNA polymerase catalytic subunit	0	1	0	1
DNA polymerase catalytic subunit	0	1	0	1
DNA polymerase alpha catalytic subunit	0	1	1	2
DNA polymerase delta catalytic subunit	0	1	0	1
DNA polymerase catalytic subunit	0	1	0	1
DNA polymerase subunit gamma-1	0	1	0	1
DNA polymerase lambda	0	1	0	1
hypoxia-inducible factor 1 alpha subunit	18	0	0	18
peroxisome proliferator-activated receptor delta	30	0	0	30
peroxisome proliferator activated receptor gamma	36	0	0	36
potassium voltage-gated channel subfamily H member 2 isoform d	45	0	0	45
Cellular tumor antigen p53	48	0	0	48
Tryptophan 5-hydroxylase 1	0	6	0	6
D(3) dopamine receptor	0	33	2	38
Alpha-2B adrenergic receptor	0	26	3	29
D(2) dopamine receptor	0	12	0	12
Alpha-2C adrenergic receptor	0	26	3	29
Alpha-2A adrenergic receptor	0	27	3	30
D(1B) dopamine receptor	0	23	0	23
D(4) dopamine receptor	0	25	1	26
E3 ubiquitin-protein ligase Mdm2	0	1	0	1
D	0	5	0	5
D	0	11	0	11
Translocator protein	0	5	4	10
Vasopressin V2 receptor	0	4	3	8
Oxytocin receptor	0	3	4	7
Vasopressin V1a receptor	0	1	2	3
Vasopressin V1a receptor	0	7	4	11
Vasopressin V1b receptor	0	3	3	6
Vasopressin V2 receptor	0	0	1	1
Vasopressin V1b receptor	0	2	1	4
Translocator protein	0	2	0	3
Oxytocin receptor	0	2	0	2
Vasopressin V2 receptor	0	3	2	5
SMAD family member 2	12	0	0	12
Fumarate hydratase	24	0	0	24
PPM1D protein	14	0	0	14
SMAD family member 3	12	0	0	12
G	33	0	0	33
polyprotein	24	0	0	24
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)	9	0	0	9
mu-type opioid receptor isoform MOR-1	0	0	4	4
transcriptional regulator ERG isoform 3	6	0	0	6
5-hydroxytryptamine receptor 2A	0	0	4	4
neuropeptide S receptor isoform A	10	0	0	10
5-hydroxytryptamine receptor 3A	0	2	2	4
Interferon beta	46	0	0	46
HLA class I histocompatibility antigen, B alpha chain	33	0	0	33
ATP-dependent translocase ABCB1	0	33	1	48
Cytochrome P450 3A4	0	37	2	45
Histamine H1 receptor	0	8	3	12
Alpha-1A adrenergic receptor	0	14	3	18
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	5	0	5
Multidrug and toxin extrusion protein 2	0	10	0	10
Inositol hexakisphosphate kinase 1	33	0	0	33
cytochrome P450 2C9, partial	33	0	0	33
Excitatory amino acid transporter 4	0	2	0	2
Glutamate transporter homolog	0	0	1	1
Carbonic anhydrase 1	0	14	0	26
Carbonic anhydrase 2	0	14	1	28
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase	0	1	0	1
5-hydroxytryptamine receptor 1D	0	6	0	9
Metabotropic glutamate receptor 1	0	1	2	4
Metabotropic glutamate receptor 2	0	1	2	4
Carbonic anhydrase-like protein, putative	0	0	0	9
Carbonic anhydrase 4	0	5	0	8
Chain A, Phospholipase A2 isoform 3	0	0	1	1
GTP-binding protein (rab7)	0	0	2	2
ras protein, partial	0	0	2	2
interleukin 8	7	0	0	7
Rac1 protein	0	0	2	2
IDH1	26	0	0	26
cell division cycle 42 (GTP binding protein, 25kDa), partial	0	0	2	2
Prostaglandin-H2 D-isomerase	0	1	0	1
Prostaglandin G/H synthase 1	0	2	0	2
Prostaglandin G/H synthase 2	0	2	0	2
Epidermal growth factor receptor	0	8	0	8
Fatty acid-binding protein, liver	0	4	0	4
Myeloperoxidase	0	5	0	5
Prostaglandin G/H synthase 1	0	5	0	5
Seed linoleate 13S-lipoxygenase-1	0	2	0	2
Glutathione hydrolase 1 proenzyme	0	1	0	1
Prostaglandin G/H synthase 1	0	7	0	8
Adenosine receptor A2a	0	6	1	14
Substance-P receptor	0	3	0	3
Prostaglandin G/H synthase 2	0	6	1	8
Urotensin-2 receptor	0	2	0	2
4-aminobutyrate aminotransferase, mitochondrial	0	2	0	2
Nuclear receptor ROR-gamma	13	2	2	17
Ras-related protein Rab-2A	0	0	2	2
Prostaglandin G/H synthase 2	0	3	0	3
Rho-associated protein kinase 2	0	1	0	1
Nicotinate phosphoribosyltransferase	0	2	0	2
Solute carrier family 22 member 20	0	4	0	4
Solute carrier family 22 member 6	0	4	0	4
glp-1 receptor, partial	23	0	0	23
cystic fibrosis transmembrane conductance regulator	0	1	0	1
short transient receptor potential channel 6 isoform 1	0	0	2	2
Muscarinic acetylcholine receptor M1	0	1	0	2
Muscarinic acetylcholine receptor M4	0	4	0	4
Reverse transcriptase/RNaseH	0	0	0	1
Muscarinic acetylcholine receptor	0	3	2	6
Gamma-aminobutyric acid type B receptor subunit 2	0	3	0	3
Gamma-aminobutyric acid type B receptor subunit 1	0	2	0	2
parathyroid hormone/parathyroid hormone-related peptide receptor precursor	10	0	0	10
Rap guanine nucleotide exchange factor 3	5	0	0	5
Zinc finger protein mex-5	0	0	1	1
Genome polyprotein	0	1	0	1
Replicase polyprotein 1ab	0	12	7	19
Hexokinase-2	0	1	0	1
Spike glycoprotein	0	3	7	10
Replicase polyprotein 1ab	0	4	7	11
Transmembrane protease serine 2	0	3	7	10
Procathepsin L	0	4	7	11
Replicase polyprotein 1a	0	3	7	10
Replicase polyprotein 1ab	0	3	7	10
Replicase polyprotein 1ab	0	5	7	12
Angiotensin-converting enzyme 2	0	3	7	10
Telomerase reverse transcriptase	0	1	0	1
Acetylcholinesterase	0	11	0	12
Lysine-specific histone demethylase 1A	0	3	0	4
Neuraminidase	0	1	0	1
Neuraminidase	0	1	0	1
Cholinesterase	0	8	0	8
Tyrosine-protein phosphatase non-receptor type 1	0	2	0	4
Acetylcholinesterase	0	13	2	16
Aldo-keto reductase family 1 member C3	0	1	0	1
Prolyl endopeptidase	0	1	0	1
Aldo-keto reductase family 1 member C2	0	1	0	1
Cholinesterase	0	9	0	10
Cytochrome P450 1B1	0	8	0	8
Gamma-aminobutyric acid receptor subunit pi	0	12	0	12
Gamma-aminobutyric acid receptor subunit delta	0	12	0	12
Gamma-aminobutyric acid receptor subunit alpha-1	0	13	4	17
Gamma-aminobutyric acid receptor subunit beta-1	0	12	1	13
Gamma-aminobutyric acid receptor subunit gamma-2	0	13	3	16
Gamma-aminobutyric acid receptor subunit beta-3	0	13	3	16
Gamma-aminobutyric acid receptor subunit alpha-5	0	13	4	17
Gamma-aminobutyric acid receptor subunit alpha-3	0	13	3	16
Gamma-aminobutyric acid receptor subunit alpha-2	0	13	2	15
Gamma-aminobutyric acid receptor subunit beta-2	0	12	2	14
Gamma-aminobutyric acid receptor subunit alpha-4	0	12	1	13
Gamma-aminobutyric acid receptor subunit epsilon	0	12	0	12
Gamma-aminobutyric acid receptor subunit alpha-6	0	12	1	13
Gamma-aminobutyric acid receptor subunit gamma-1	0	12	0	12
Gamma-aminobutyric acid receptor subunit gamma-3	0	12	0	12
Gamma-aminobutyric acid receptor subunit theta	0	12	0	12
Kappa-type opioid receptor	0	14	1	16
Kappa-type opioid receptor	0	30	9	44
Acetylcholine receptor subunit alpha	0	5	3	8
Acetylcholine receptor subunit gamma	0	5	3	8
Integrin alpha-5	0	1	0	1
Acetylcholine receptor subunit beta	0	5	3	8
UDP-glucuronosyltransferase 2B7	0	3	0	7
Neuronal acetylcholine receptor subunit beta-2	0	8	2	12
UDP-glucuronosyltransferase 1-6	0	2	0	3
Cytochrome P450 2B6	0	3	1	6
UDP-glucuronosyltransferase 1A1	0	5	0	6
Neuronal acetylcholine receptor subunit beta-4	0	7	2	11
Neuronal acetylcholine receptor subunit alpha-3	0	7	2	9
Cytochrome P450 2C19	0	15	1	18
UDP-glucuronosyltransferase 2B10	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-7	0	5	2	7
Neuronal acetylcholine receptor subunit alpha-4	0	8	2	12
Acetylcholine receptor subunit delta	0	5	3	8
Beta-2 adrenergic receptor	0	8	0	9
Angiotensin-converting enzyme	0	1	0	1
Beta-1 adrenergic receptor	0	7	1	9
Beta-3 adrenergic receptor	0	6	0	6
Alpha-2A adrenergic receptor	0	2	0	2
5-hydroxytryptamine receptor 2A	0	1	0	1
Lysosomal alpha-glucosidase	0	2	0	2
Chain A, Glycogen Phosphorylase	0	1	0	1
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Chitinase	0	1	0	1
Potassium channel subfamily K member 2	0	6	9	15
Glycogen phosphorylase, muscle form	0	2	0	2
Renin	0	1	0	1
Glycogen phosphorylase, liver form	0	1	0	1
Glycogen phosphorylase, muscle form	0	1	0	1
Adenosine receptor A3	0	14	1	15
Amine oxidase [flavin-containing] A	0	8	0	9
Amine oxidase [flavin-containing] B	0	11	1	13
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	3	0	3
Adenosine receptor A3	0	1	0	1
Adenosine receptor A2a	0	4	3	8
Adenosine receptor A2b	0	1	0	2
Adenosine receptor A2b	0	3	1	5
Adenosine receptor A1	0	6	1	9
Vasopressin V2 receptor	0	0	0	1
Adenosine receptor A2a	0	1	0	1
Adenosine receptor A1	0	1	0	1
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	1	0	1
Adenylate cyclase type 1	0	1	0	2
Chitotriosidase-1	0	1	0	1
Adenosine receptor A2b	0	1	0	2
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	1	0	1
Palmitoleoyl-protein carboxylesterase NOTUM	0	2	2	4
Endochitinase B1	0	1	0	1
Phosphodiesterase	0	1	0	1
Broad substrate specificity ATP-binding cassette transporter ABCG2	0	9	1	11
Guanine deaminase	0	2	0	3
L-lactate dehydrogenase A chain	0	2	0	2
Cytochrome P450 1A1	0	3	0	3
Cytochrome P450 2C11	0	2	0	2
Cytochrome P450 2D6	0	37	2	41
Steroid 17-alpha-hydroxylase/17,20 lyase	0	1	0	1
Cytochrome P450 3A5	0	3	0	3
Cytochrome P450 3A7	0	2	0	2
Caspase-1	0	0	1	1
Mu-type opioid receptor	0	38	10	52
Peroxisome proliferator-activated receptor gamma	0	0	5	5
Delta-type opioid receptor	0	24	7	35
N-acylethanolamine-hydrolyzing acid amidase	0	1	0	1
Heat sensitive channel TRPV3	0	1	1	2
Sigma intracellular receptor 2	0	3	0	3
Transient receptor potential cation channel subfamily A member 1	0	1	2	3
Transient receptor potential cation channel subfamily M member 8	0	1	0	1
Transient receptor potential cation channel subfamily V member 4	0	2	1	3
G-protein coupled receptor 55	0	1	2	3
Diacylglycerol lipase-alpha	0	1	0	1
Chain A, Beta-lactamase	24	0	0	24
Vpr	3	0	0	3
Major prion protein	0	0	5	5
Sodium channel protein type 1 subunit alpha	0	5	0	5
Sodium channel protein type 2 subunit alpha	0	9	0	9
Sodium channel protein type 3 subunit alpha	0	4	0	4
Frizzled-8	0	0	1	1
P2X purinoceptor 4	0	2	0	2
Chain A, serum paraoxonase	0	1	0	1
Carbonic anhydrase 12	0	6	0	13
Carbonic anhydrase 3	0	5	0	11
Neutrophil cytosol factor 1	0	1	0	1
Carbonic anhydrase 4	0	5	0	12
Carbonic anhydrase 6	0	5	0	12
Carbonic anhydrase 5A, mitochondrial	0	5	1	13
Carbonic anhydrase 7	0	5	0	12
Carbonic anhydrase 9	0	7	0	15
Carbonic anhydrase 13	0	3	0	6
Poly [ADP-ribose] polymerase tankyrase-2	0	1	0	1
Carbonic anhydrase 14	0	4	0	11
Carbonic anhydrase 5B, mitochondrial	0	5	0	12
Chain A, Carbonic anhydrase II	0	1	0	1
Carbonic anhydrase	0	0	0	3
Carbonic anhydrase	0	3	0	3
caspase 7, apoptosis-related cysteine protease	13	0	0	13
Carbonic anhydrase	0	3	0	3
Carbonic anhydrase	0	3	0	3
Carbonic anhydrase	0	3	0	3
caspase-3	13	0	0	13
thyrotropin-releasing hormone receptor	4	0	0	4
Caspase-7	9	0	0	9
interferon gamma precursor	0	0	0	3
prostaglandin E2 receptor EP2 subtype	0	0	0	2
caspase-3	9	0	0	9
Prostaglandin E synthase	0	1	0	1
3-phosphoinositide-dependent protein kinase 1	0	1	0	1
Cytochrome c oxidase subunit 1	0	1	0	1
Cytochrome c oxidase subunit 2	0	1	0	1
Catechol O-methyltransferase	0	1	0	1
Cytochrome c oxidase subunit 2	0	1	0	1
Polyunsaturated fatty acid 5-lipoxygenase	0	2	0	2
Quinolone resistance protein NorA	0	3	0	4
Beta-3 adrenergic receptor	0	10	1	11
Calpain-2 catalytic subunit	0	1	0	1
Prostaglandin G/H synthase 1	0	1	0	1
Cruzipain	0	1	0	1
Sodium/hydrogen exchanger 1	0	1	0	1
Indoleamine 2,3-dioxygenase 1	0	4	0	4
Delta-type opioid receptor	0	18	3	26
Delta-type opioid receptor	0	15	4	21
Mu-type opioid receptor	0	19	4	26
Bifunctional epoxide hydrolase 2	0	1	0	1
Prostaglandin G/H synthase 2	0	1	0	1
Carbonic anhydrase	0	3	0	9
Carbonic anhydrase	0	3	0	10
Carbonic anhydrase	0	2	0	2
Beta-carbonic anhydrase 1	0	3	0	3
Carbonic anhydrase 2	0	3	0	3
Prostaglandin G/H synthase 2	0	1	0	1
Mitogen-activated protein kinase 14	0	1	0	1
Carbonic anhydrase, alpha family	0	3	0	3
Carbonic anhydrase	0	3	0	10
Carbonic anhydrase	0	2	0	9
Carbonic anhydrase	0	3	0	10
Carbonic anhydrase	0	3	0	3
Sigma intracellular receptor 2	0	10	0	10
Delta carbonic anhydrase	0	3	0	3
Prostaglandin G/H synthase 1	0	1	0	1
Carbonic anhydrase	0	3	0	10
Prostaglandin G/H synthase 1	0	1	0	1
Cyclooxygenase-2	0	1	0	1
Rap guanine nucleotide exchange factor 4	3	0	0	3
Carbonic anhydrase 15	0	5	0	11
P2Y purinoceptor 12	0	1	0	1
Gamma-aminobutyric acid receptor subunit alpha-1	0	6	0	7
Gamma-aminobutyric acid receptor subunit beta-1	0	6	0	7
Gamma-aminobutyric acid receptor subunit alpha-2	0	6	0	7
Gamma-aminobutyric acid receptor subunit alpha-3	0	6	0	7
Gamma-aminobutyric acid receptor subunit alpha-4	0	6	0	7
Gamma-aminobutyric acid receptor subunit gamma-2	0	6	0	7
Cholecystokinin receptor type A	0	4	0	4
Gastrin/cholecystokinin type B receptor	0	4	0	4
Proteasome subunit beta type-11	0	0	0	1
NADPH oxidase 1	0	4	0	4
Snq2p	0	0	0	9
Adenylate cyclase type 1	0	4	0	4
histone deacetylase 9 isoform 3	3	0	0	3
ras-related protein Rab-9A	18	0	0	18
Proteasome subunit alpha type-7	0	0	0	1
Transient receptor potential cation channel subfamily V member 1	0	2	0	2
Albumin	0	2	9	16
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	0	3	0	3
Receptor tyrosine-protein kinase erbB-2	0	4	0	4
Major prion protein	0	0	1	1
Tyrosine-protein kinase Fyn	0	7	0	7
Cys-loop ligand-gated ion channel	0	1	0	1
Calmodulin-1	0	4	2	6
Polyunsaturated fatty acid lipoxygenase ALOX15	0	5	0	5
Sphingomyelin phosphodiesterase	0	2	0	2
Proteasome subunit beta type-1	0	0	0	1
Substance-K receptor	0	12	0	12
Adenylate cyclase type 3	0	4	0	4
Proteasome subunit alpha type-1	0	0	0	1
Proteasome subunit alpha type-2	0	0	0	1
Proteasome subunit alpha type-3	0	0	0	1
Proteasome subunit alpha type-4	0	0	0	1
Adenylate cyclase type 2	0	4	0	4
Adenylate cyclase type 4	0	4	0	4
Proteasome subunit beta type-8	0	0	0	1
Proteasome subunit beta type-9	0	0	0	1
Proteasome subunit alpha type-5	0	0	0	1
Proteasome subunit beta type-4	0	0	0	1
Proteasome subunit beta type-6	0	0	0	1
Proteasome subunit beta type-5	0	0	0	1
Trypanothione reductase	0	12	0	12
Melanocortin receptor 4	0	2	0	2
Melanocortin receptor 5	0	6	0	6
Pleiotropic ABC efflux transporter of multiple drugs	0	9	0	18
Adenylate cyclase type 8	0	4	0	4
Proteasome subunit beta type-10	0	0	0	1
Melanocortin receptor 3	0	2	0	2
Proteasome subunit beta type-3	0	0	0	1
Proteasome subunit beta type-2	0	0	0	1
Gastrin/cholecystokinin type B receptor	0	3	0	3
Proteasome subunit alpha type-6	0	0	4	5
Calmodulin	0	1	4	5
Aldehyde oxidase 1	0	1	0	1
Adenylate cyclase type 6	0	4	0	4
Adenylate cyclase type 5	0	4	0	4
Aldehyde oxidase	0	3	0	5
Adenylyl cyclase 7	0	4	0	4
Proteasome subunit alpha-type 8	0	0	0	1
Proteasome subunit beta type-7	0	0	0	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein	0	0	1	1
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Choline-binding protein	0	0	1	1
Solute carrier family 22 member 1	0	1	0	2
Solute carrier family 22 member 2	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-3	0	5	4	10
Neuronal acetylcholine receptor subunit alpha-2	0	4	3	8
Neuronal acetylcholine receptor subunit beta-3	0	3	4	8
Neuronal acetylcholine receptor subunit beta-4	0	5	4	10
Neuronal acetylcholine receptor subunit alpha-5	0	3	3	7
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
Choline O-acetyltransferase	0	2	0	3
Neuronal acetylcholine receptor subunit alpha-6	0	3	4	8
Neuronal acetylcholine receptor subunit alpha-9	0	3	3	7
Neuronal acetylcholine receptor subunit alpha-7	0	9	4	14
High affinity choline transporter 1	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-10	0	3	3	7
DNA gyrase subunit B	0	1	0	1
DNA gyrase subunit A	0	1	0	1
DNA gyrase subunit B	0	1	0	2
DNA gyrase subunit A	0	2	0	5
DNA gyrase subunit B	0	2	0	5
DNA topoisomerase 4 subunit A	0	1	0	1
DNA topoisomerase 4 subunit B	0	1	0	2
DNA topoisomerase 4 subunit A	0	1	0	2
DNA topoisomerase 2-alpha	0	2	0	6
DNA gyrase subunit A	0	1	0	2
Multidrug resistance protein MdtK	0	0	1	1
DNA gyrase subunit B	0	2	0	3
DNA gyrase subunit A	0	2	0	3
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	0	0	1
DNA topoisomerase 4 subunit A	0	1	0	1
DNA topoisomerase 4 subunit B	0	1	0	1
Integrase	0	2	0	2
NPC intracellular cholesterol transporter 1 precursor	14	0	0	14
Sodium-dependent noradrenaline transporter	0	5	0	5
Aldo-keto reductase family 1 member B1	0	3	0	3
Aromatase	0	1	0	1
Sodium-dependent serotonin transporter	0	5	0	5
Sodium-dependent dopamine transporter	0	6	0	6
Transporter	0	20	2	23
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	2	0	2
General amino-acid permease GAP1	0	0	0	1
Nitric oxide synthase, brain	0	1	0	1
Nitric oxide synthase, brain	0	1	0	1
urokinase-type plasminogen activator precursor	6	0	0	6
plasminogen precursor	6	0	0	6
urokinase plasminogen activator surface receptor precursor	6	0	0	6
streptokinase A precursor	0	0	4	4
Solute carrier organic anion transporter family member 1B3	0	6	0	7
Solute carrier organic anion transporter family member 1B1	0	6	0	8
Trypanothione reductase	0	1	0	1
Envelope glycoprotein	0	0	4	4
2,3-bisphosphoglycerate-independent phosphoglycerate mutase	2	0	0	2
Translocator protein	0	2	0	2
Translocator protein	0	5	1	7
Beta-1 adrenergic receptor	0	2	2	5
Alpha-1B adrenergic receptor	0	0	2	2
Membrane primary amine oxidase	0	1	0	1
Solute carrier family 22 member 3	0	10	0	11
Alpha-1A adrenergic receptor	0	3	2	5
Alpha-2B adrenergic receptor	0	1	0	2
Alpha-2C adrenergic receptor	0	1	0	2
Alpha-2A adrenergic receptor	0	1	0	2
Nischarin	0	2	0	2
Nischarin	0	3	0	3
bromodomain adjacent to zinc finger domain 2B	17	0	0	17
transient receptor potential cation channel subfamily V member 1	3	0	0	3
Endothelin receptor type B	0	3	0	3
5-hydroxytryptamine receptor 3A	0	4	0	4
Endothelin receptor type B	0	3	0	3
D(2) dopamine receptor	0	2	0	2
D(3) dopamine receptor	0	2	0	2
D(2) dopamine receptor	0	7	0	7
5-hydroxytryptamine receptor 2B	0	3	0	3
5-hydroxytryptamine receptor 4	0	2	0	2
Transporter	0	6	0	6
Cholecystokinin receptor type A	0	2	0	2
5-hydroxytryptamine receptor 1A	0	2	0	2
Histamine H4 receptor	0	6	5	11
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain H, Fab M82G2, Heavy chain	0	0	1	1
Chain L, Fab M82G2, Light chain	0	0	1	1
Chain H, Fab M82g2, Heavy Chain	0	0	1	1
Chain L, Fab M82g2, Light Chain	0	0	1	1
Amyloid-beta precursor protein	2	5	0	7
Fatty acid-binding protein, heart	0	1	0	1
Muscarinic acetylcholine receptor M2	0	1	1	2
Liver carboxylesterase 1	0	2	0	4
Lysosomal Pro-X carboxypeptidase	0	1	0	1
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	2	0	2
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	3	0	3
Leukotriene B4 receptor 1	0	1	0	2
Leukotriene B4 receptor 2	0	1	0	2
Cytochrome P450 2D1	0	3	0	3
Cytochrome P450 2D26	0	3	0	3
Cytochrome P450 2D3	0	3	0	3
Kappa-type opioid receptor	0	9	3	14
Mu-type opioid receptor	0	9	3	16
Cytochrome P450 2D4	0	3	0	3
Mas-related G-protein coupled receptor member X2	0	0	7	7
GALC protein	11	0	0	11
nonstructural protein 1	11	0	0	11
Sex hormone-binding globulin	0	0	1	1
Corticosteroid-binding globulin	0	2	0	2
Mineralocorticoid receptor	0	2	2	4
Androgen receptor	0	10	0	10
C-8 sterol isomerase	0	5	0	5
Solute carrier organic anion transporter family member 1A1	0	2	0	2
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	0	5	0	5
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
Proton-coupled amino acid transporter 1	0	5	0	5
Chain A, N-methyl-D-aspartate Receptor Subunit 1	0	1	0	1
Chain A, N-methyl-D-aspartate Receptor Subunit 1	0	1	0	1
Chain A, N-methyl-D-aspartate Receptor Subunit 1	0	1	0	1
D-alanine--D-alanine ligase	0	1	0	1
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase	0	1	0	1
chaperonin GroEL	1	0	0	1
Glycogen phosphorylase, brain form	0	2	0	2
Glycogen phosphorylase, muscle form	0	2	0	2
Histone-lysine N-methyltransferase SETD7	0	2	0	2
nuclear receptor subfamily 1, group I, member 2	5	0	0	5
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	12	0	0	12
Glucocorticoid receptor	0	8	2	15
Progesterone receptor	0	3	0	4
Glycine receptor subunit alpha-1	0	8	0	8
Androgen receptor	0	7	0	7
Glycine receptor subunit beta	0	8	0	8
Glycine receptor subunit alpha-2	0	8	0	8
Glycine receptor subunit alpha-3	0	8	0	8
ORF73	0	0	1	1
Histamine H3 receptor	0	3	0	3
Solute carrier family 22 member 4	0	1	0	1
Amine oxidase [flavin-containing] B	0	5	0	6
Amine oxidase [flavin-containing] B	0	3	0	4
Trace amine-associated receptor 1	0	0	1	1
Trace amine-associated receptor 1	0	0	2	2
Trace amine-associated receptor 1	0	0	3	3
Gamma-aminobutyric acid	0	2	2	4
Alpha-1-acid glycoprotein 1	0	0	0	1
Gamma-aminobutyric acid receptor subunit alpha-6	0	2	2	4
Gamma-aminobutyric acid receptor subunit gamma-2	0	2	2	4
Gamma-aminobutyric acid receptor subunit delta	0	2	2	4
Gamma-aminobutyric acid receptor subunit alpha-2	0	2	2	4
Gamma-aminobutyric acid receptor subunit alpha-3	0	2	2	4
Gamma-aminobutyric acid receptor subunit gamma-3	0	2	2	4
Gamma-aminobutyric acid receptor subunit beta-1	0	2	2	4
Gamma-aminobutyric acid receptor subunit alpha-1	0	3	2	5
Gamma-aminobutyric acid receptor subunit beta-3	0	2	2	4
Gamma-aminobutyric acid receptor subunit alpha-5	0	2	2	4
Gamma-aminobutyric acid receptor subunit pi	0	2	2	4
Sphingosine-1-phosphate lyase 1	0	1	0	1
Gamma-aminobutyric acid receptor subunit alpha-4	0	2	2	4
Gamma-aminobutyric acid receptor subunit theta	0	2	2	4
Gamma-aminobutyric acid receptor subunit gamma-1	0	2	2	4
PAX8	0	0	0	1
STAT3, partial	0	1	0	1
tumor necrosis factor	3	0	0	3
signal transducer and activator of transcription 1-alpha/beta isoform alpha	0	1	0	1
Solute carrier organic anion transporter family member 1A4	0	3	0	6
Sodium/potassium-transporting ATPase subunit alpha-1	0	3	0	3
Sodium/potassium-transporting ATPase subunit beta-1	0	3	0	3
Sodium/potassium-transporting ATPase subunit alpha-2	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-3	0	1	0	1
ATP-dependent translocase ABCB1	0	9	0	9
Sodium/potassium-transporting ATPase subunit beta-1	0	1	0	1
Sodium/potassium-transporting ATPase subunit alpha-3	0	2	0	2
Sodium/potassium-transporting ATPase subunit beta-2	0	2	0	2
ATP-dependent translocase ABCB1	0	9	0	10
Sodium/potassium-transporting ATPase subunit alpha-2	0	3	0	3
Sodium/potassium-transporting ATPase subunit alpha-1	0	1	0	1
Sodium/potassium-transporting ATPase subunit beta-3	0	2	0	2
Sodium/potassium-transporting ATPase subunit gamma	0	2	0	2
Sodium/potassium-transporting ATPase subunit alpha-4	0	2	0	2
Sodium/potassium-transporting ATPase subunit alpha-4	0	1	0	1
Solute carrier organic anion transporter family member 4C1	0	1	0	3
Solute carrier organic anion transporter family member 4C1	0	0	0	2
Solute carrier organic anion transporter family member 1A4	0	0	0	1
Synaptic vesicular amine transporter	0	7	2	9
polyunsaturated fatty acid lipoxygenase ALOX12	2	0	0	2
runt-related transcription factor 1 isoform AML1b	2	0	0	2
core-binding factor subunit beta isoform 2	2	0	0	2
Caspase-7	3	0	0	3
Voltage-dependent L-type calcium channel subunit alpha-1C	0	8	0	8
Voltage-dependent L-type calcium channel subunit alpha-1C	0	6	0	6
Voltage-dependent L-type calcium channel subunit alpha-1D	0	4	0	4
Voltage-dependent L-type calcium channel subunit alpha-1S	0	4	0	4
Potassium voltage-gated channel subfamily A member 1	0	2	0	2
Kappa-type opioid receptor	0	9	5	15
Acetylcholinesterase	0	2	0	2
Amine oxidase [flavin-containing] A	0	4	0	5
Amine oxidase [flavin-containing] A	0	3	0	4
Acetylcholinesterase	0	3	0	3
Acetylcholinesterase	0	4	0	4
Acetylcholinesterase	0	2	0	2
Beta-secretase 1	0	1	0	1
Cholinesterase	0	2	0	2
Acetylcholine receptor subunit epsilon	0	1	2	3
Acyl-CoA:cholesterol acyltransferase	0	2	0	2
Carboxylic ester hydrolase	0	2	0	3
Carboxylic ester hydrolase	0	4	0	4
Histamine H3 receptor	0	2	1	4
Nuclear receptor subfamily 1 group I member 2	0	0	4	4
Transient receptor potential cation channel subfamily A member 1	0	0	2	3
Glycine receptor subunit alpha-1	0	0	4	4
N-arachidonyl glycine receptor	0	0	1	1
Lysophosphatidylserine lipase ABHD12	0	1	0	1
Monoglyceride lipase	0	1	0	1
Monoacylglycerol lipase ABHD6	0	1	0	1
N-acetyltransferase Eis	0	3	0	3
chaperonin-containing TCP-1 beta subunit homolog	3	0	0	3
ubiquitin-conjugating enzyme E2 N	0	2	0	2
protein AF-9 isoform a	0	0	0	3
histone-lysine N-methyltransferase 2A isoform 2 precursor	9	0	0	9
Estrogen receptor	0	4	0	4
Alpha-synuclein	5	3	0	8
Opioid receptor, delta 1b	0	2	0	2
Opioid receptor homologue	0	2	0	2
Proenkephalin-B	0	0	1	1
Mu-type opioid receptor	0	2	0	2
Adenylate cyclase	0	1	0	1
Tyrosine-protein kinase Lck	0	2	1	3
Beta-2 adrenergic receptor	0	7	1	8
Thromboxane-A synthase	0	4	0	4
5-hydroxytryptamine receptor 1B	0	6	1	7
Motilin receptor	0	0	1	1
acid sphingomyelinase	1	0	0	1
low molecular weight phosphotyrosine protein phosphatase isoform c	0	1	0	1
serine/threonine-protein kinase PLK1	5	0	0	5
Motilin receptor	0	1	1	2
30S ribosomal protein S6	0	2	1	3
30S ribosomal protein S7	0	2	1	3
50S ribosomal protein L15	0	2	1	3
60 kDa chaperonin	0	3	0	3
50S ribosomal protein L10	0	2	1	3
50S ribosomal protein L11	0	2	1	3
50S ribosomal protein L7/L12	0	2	1	3
50S ribosomal protein L19	0	2	1	3
50S ribosomal protein L1	0	2	1	3
50S ribosomal protein L20	0	2	1	3
50S ribosomal protein L27	0	2	1	3
50S ribosomal protein L28	0	2	1	3
50S ribosomal protein L29	0	2	1	3
50S ribosomal protein L31	0	2	1	3
50S ribosomal protein L31 type B	0	2	1	3
50S ribosomal protein L32	0	2	1	3
50S ribosomal protein L33	0	2	1	3
50S ribosomal protein L34	0	2	1	3
50S ribosomal protein L35	0	2	1	3
50S ribosomal protein L36	0	2	1	3
30S ribosomal protein S10	0	2	1	3
30S ribosomal protein S11	0	2	1	3
30S ribosomal protein S12	0	2	1	3
30S ribosomal protein S13	0	2	1	3
30S ribosomal protein S16	0	2	1	3
30S ribosomal protein S18	0	2	1	3
30S ribosomal protein S19	0	2	1	3
30S ribosomal protein S20	0	2	1	3
30S ribosomal protein S2	0	2	1	3
30S ribosomal protein S3	0	2	1	3
30S ribosomal protein S4	0	2	1	3
30S ribosomal protein S5	0	2	1	3
30S ribosomal protein S8	0	2	1	3
30S ribosomal protein S9	0	2	1	3
50S ribosomal protein L13	0	2	1	3
50S ribosomal protein L14	0	2	1	3
50S ribosomal protein L16	0	2	1	3
50S ribosomal protein L23	0	2	1	3
30S ribosomal protein S15	0	2	1	3
50S ribosomal protein L17	0	2	1	3
50S ribosomal protein L21	0	2	1	3
50S ribosomal protein L30	0	2	1	3
50S ribosomal protein L6	0	2	1	3
30S ribosomal protein S14	0	2	1	3
30S ribosomal protein S17	0	2	1	3
30S ribosomal protein S1	0	2	1	3
50S ribosomal protein L18	0	2	1	3
60 kDa heat shock protein, mitochondrial	0	3	0	3
Chitinase B	0	1	0	1
Low molecular weight phosphotyrosine protein phosphatase	0	1	0	1
50S ribosomal protein L2	0	2	1	3
50S ribosomal protein L3	0	2	1	3
50S ribosomal protein L24	0	2	1	3
50S ribosomal protein L4	0	2	1	3
50S ribosomal protein L22	0	2	1	3
10 kDa heat shock protein, mitochondrial	0	3	0	3
50S ribosomal protein L5	0	2	1	3
30S ribosomal protein S21	0	2	1	3
50S ribosomal protein L25	0	2	1	3
Thiosulfate sulfurtransferase	0	3	0	3
50S ribosomal protein L36 2	0	2	1	3
60 kDa chaperonin	0	3	0	3
10 kDa chaperonin	0	3	0	3
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	0	1	0	1
3-oxo-5-alpha-steroid 4-dehydrogenase 1	0	2	0	2
3-oxo-5-alpha-steroid 4-dehydrogenase 1	0	3	0	3
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	2	0	2
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	3	0	3
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase	0	1	0	1
muscleblind-like protein 1 isoform 1	11	0	0	11
Voltage-dependent T-type calcium channel subunit alpha-1G	0	0	2	2
Voltage-dependent T-type calcium channel subunit alpha-1H	0	0	1	1
Voltage-dependent L-type calcium channel subunit beta-1	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	1	0	1
Voltage-dependent N-type calcium channel subunit alpha-1B	0	1	0	1
Voltage-dependent T-type calcium channel subunit alpha-1I	0	0	1	1
Prostaglandin D2 receptor 2	0	1	0	1
Cytochrome P450 2C8	0	6	0	6
Dipeptidyl peptidase 4	0	1	0	1
Potassium voltage-gated channel subfamily C member 1	0	1	0	1
Gastrin/cholecystokinin type B receptor	0	1	0	1
Cocaine esterase	0	3	0	4
Arylacetamide deacetylase	0	0	0	1
Arylacetamide deacetylase	0	0	0	1
Arylacetamide deacetylase	0	0	0	1
Cytochrome P450 1A2	0	2	0	2
Gamma-aminobutyric acid receptor subunit rho-3	0	0	1	1
Hsf1 protein	0	0	2	3
Sodium- and chloride-dependent GABA transporter 1	0	2	0	2
Gamma-aminobutyric acid receptor subunit rho-1	0	0	2	2
Gamma-aminobutyric acid receptor subunit rho-2	0	0	1	1
Sodium- and chloride-dependent GABA transporter 1	0	1	0	1
Sodium- and chloride-dependent taurine transporter	0	1	0	1
Sodium- and chloride-dependent GABA transporter 2	0	2	0	2
Sodium- and chloride-dependent GABA transporter 3	0	2	0	2
Sodium- and chloride-dependent GABA transporter 1	0	2	0	2
Sodium- and chloride-dependent GABA transporter 2	0	3	0	3
Sodium- and chloride-dependent GABA transporter 3	0	3	0	3
Sodium- and chloride-dependent betaine transporter	0	2	0	2
Sodium- and chloride-dependent betaine transporter	0	1	0	1
Sodium- and chloride-dependent GABA transporter 3	0	1	0	1
4-aminobutyrate aminotransferase, mitochondrial	0	1	0	2
4-aminobutyrate aminotransferase, mitochondrial	0	2	0	3
Sterol O-acyltransferase 1	0	0	1	1
Platelet glycoprotein VI	0	0	1	1
Sodium- and chloride-dependent GABA transporter 2	0	1	0	1
Succinate-semialdehyde dehydrogenase, mitochondrial	0	1	0	1
Asialoglycoprotein receptor 1	0	1	1	2
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2	0	1	0	1
Chain A, Glutamate Receptor Subunit 2	0	1	0	1
Chain B, Glutamate Receptor Subunit 2	0	1	0	1
Chain A, Slr1257 protein	0	0	1	1
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing]	0	1	0	1
beta-2 adrenergic receptor	3	0	0	3
Metabotropic glutamate receptor 8	0	2	0	2
Glutathione reductase, mitochondrial	0	4	0	4
Bifunctional aspartokinase/homoserine dehydrogenase 1	0	1	0	1
Prothrombin	0	0	2	2
ATP-citrate synthase	0	1	0	1
Metabotropic glutamate receptor 1	0	2	1	3
Metabotropic glutamate receptor 2	0	0	1	1
Metabotropic glutamate receptor 3	0	0	1	1
Metabotropic glutamate receptor 4	0	1	1	2
Metabotropic glutamate receptor 5	0	1	2	3
Metabotropic glutamate receptor 6	0	0	1	1
Metabotropic glutamate receptor 7	0	0	1	1
Metabotropic glutamate receptor 5	0	1	2	4
Metabotropic glutamate receptor 8	0	0	1	1
Excitatory amino acid transporter 3	0	0	0	1
Glutamate racemase	0	0	0	1
Metabotropic glutamate receptor 8	0	1	1	2
Glutamate carboxypeptidase 2	0	1	0	1
Metabotropic glutamate receptor 7	0	1	1	3
Metabotropic glutamate receptor 3	0	1	1	3
Metabotropic glutamate receptor 4	0	1	1	3
Glutamate racemase	0	0	0	1
Prolyl 4-hydroxylase	0	1	0	1
Alpha-ketoglutarate-dependent dioxygenase FTO	0	1	0	1
Chain A, Glutamine Binding Protein	0	0	1	1
Neutral amino acid transporter A	0	2	0	2
Asc-type amino acid transporter 1	0	1	0	1
Neutral amino acid transporter B(0)	0	2	0	2
Amino acid transporter	0	2	0	2
Sodium- and chloride-dependent glycine transporter 1	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	8	0	9
Serine racemase	0	1	0	1
Olfactory receptor 51E2	0	0	1	1
Sodium- and chloride-dependent glycine transporter 2	0	1	0	1
POU domain, class 2, transcription factor 1	0	0	0	1
Hypoxanthine-guanine phosphoribosyltransferase	0	0	0	1
Ricin	0	1	0	1
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase	0	0	1	1
Purine nucleoside phosphorylase	0	0	1	2
Shiga toxin subunit A	0	1	0	1
UDP-glucuronosyltransferase 1A9	0	2	0	4
Vitamin D-binding protein	0	1	0	1
HLA class I histocompatibility antigen, A alpha chain	0	0	2	2
Integrin beta-1	0	1	0	1
Integrin alpha-4	0	1	0	1
Carbonyl reductase [NADPH] 1	0	0	0	1
5-hydroxytryptamine receptor 2A	0	2	1	3
AP-2 complex subunit sigma	0	1	0	1
Calcitonin gene-related peptide type 1 receptor	0	1	0	1
Genome polyprotein	0	3	0	3
Zinc finger protein 664	0	1	0	1
Vesicular acetylcholine transporter	0	3	0	3
Protease	0	8	2	14
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, Protein (female-specific Histamine Binding Protein 2)	0	0	1	1
aryl hydrocarbon receptor nuclear translocator	0	0	0	1
transforming acidic coiled-coil-containing protein 3	0	0	0	1
Plasma kallikrein	0	0	0	6
Macrophage migration inhibitory factor	0	2	0	2
Histamine H3 receptor	0	2	0	2
Histamine N-methyltransferase	0	1	0	1
Glutaminyl-peptide cyclotransferase	0	2	0	2
Equilibrative nucleoside transporter 4	0	0	0	1
Histamine H4 receptor	0	1	2	3
Histamine H4 receptor	0	1	2	3
Histamine H4 receptor	0	1	0	1
Carbonic anhydrase 13	0	2	0	8
Chain A, HISTIDINE-BINDING PROTEIN	0	0	1	1
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
Histidine-binding periplasmic protein	0	0	1	1
ClpP	3	0	0	3
Solute carrier family 22 member 8	0	2	0	3
Uracil nucleotide/cysteinyl leukotriene receptor	0	2	0	2
Chain A, PROTEIN (PROTEASE)	0	1	0	1
Chain B, PROTEIN (PROTEASE)	0	1	0	1
Chain A, PROTEIN (PROTEASE)	0	1	0	1
Chain B, PROTEIN (PROTEASE)	0	1	0	1
Chain A, HIV-1 PROTEASE	0	1	0	1
Chain B, HIV-1 PROTEASE	0	1	0	1
Chain A, HIV-II PROTEASE	0	1	0	1
Chain B, HIV-II PROTEASE	0	1	0	1
Chain A, POL polyprotein	0	0	1	1
Chain B, POL polyprotein	0	0	1	1
Chain A, POL polyprotein	0	0	1	1
Chain B, POL polyprotein	0	0	1	1
Chain A, POL polyprotein	0	0	1	1
Chain B, POL polyprotein	0	0	1	1
Chain A, POL polyprotein	0	0	1	1
Chain B, POL polyprotein	0	0	1	1
Chain A, protease RETROPEPSIN	0	1	0	1
Chain B, protease RETROPEPSIN	0	1	0	1
Chain A, protease RETROPEPSIN	0	1	0	1
Chain B, protease RETROPEPSIN	0	1	0	1
Chain A, protease RETROPEPSIN	0	1	0	1
Chain B, protease RETROPEPSIN	0	1	0	1
Chain A, POL polyprotein	0	2	0	2
Chain B, POL polyprotein	0	2	0	2
Chain A, POL polyprotein	0	2	0	2
Chain B, POL polyprotein	0	2	0	2
Chain A, HIV-1 protease	0	1	0	1
Chain B, HIV-1 protease	0	1	0	1
Chain A, Pol polyprotein	0	1	0	1
Chain B, Pol polyprotein	0	1	0	1
Chain A, Pol polyprotein	0	1	0	1
Chain B, Pol polyprotein	0	1	0	1
Chain A, Pol polyprotein	0	1	0	1
Chain B, Pol polyprotein	0	1	0	1
Chain A, Pol polyprotein	0	1	0	1
Chain B, Pol polyprotein	0	1	0	1
Chain A, Hiv-1 Protease	0	1	0	1
Chain B, Hiv-1 Protease	0	1	0	1
Chain A, Hiv-1 Protease	0	1	0	1
Chain B, Hiv-1 Protease	0	1	0	1
Chain A, Hiv-1 Protease	0	1	0	1
Chain B, Hiv-1 Protease	0	1	0	1
Gag-Pol polyprotein	0	3	0	3
Gag-Pol polyprotein	0	2	0	2
Gag-Pol polyprotein	0	2	0	2
Gag polyprotein	0	1	0	1
Gag-Pol polyprotein	0	2	0	2
Gag-Pol polyprotein	0	4	0	4
Gag-Pol polyprotein	0	2	0	2
Thromboxane-A synthase	0	0	0	2
Protease	0	4	2	6
Protease	0	1	0	1
Peptide deformylase 1A, chloroplastic/mitochondrial	0	1	0	1
Peptide deformylase	0	1	0	1
Chain A, ADENOSINE DEAMINASE	0	1	0	1
Chain A, ADENOSINE DEAMINASE	0	1	0	1
Chain A, Membrane lipoprotein tmpC	0	0	1	1
Chain A, Membrane lipoprotein tmpC	0	0	1	1
Chain A, Membrane lipoprotein tmpC	0	0	1	1
glycogen synthase kinase-3 beta isoform 1	0	0	1	1
Adenosylhomocysteinase	0	1	0	2
Adenosine deaminase	0	1	0	1
Chain B, Pulmonary surfactant-associated protein D	0	1	0	1
Chain A, Pulmonary surfactant-associated protein D	0	1	0	1
Sodium/myo-inositol cotransporter 2	0	1	0	1
Chain A, BETA-SPECTRIN	0	0	1	1
Chain A, Phospholipase C Delta-1	0	0	1	1
Chain A, Inositol 1,4,5-trisphosphate receptor type 1	0	0	1	1
Inositol-trisphosphate 3-kinase A	0	1	0	1
Inositol 1,4,5-trisphosphate receptor type 1	0	0	2	2
Inositol 1,4,5-trisphosphate receptor type 2	0	1	0	1
Inositol 1,4,5-trisphosphate receptor type 3	0	1	1	2
Inositol polyphosphate-5-phosphatase A	0	1	0	1
Inositol 1,4,5-trisphosphate receptor type 1	0	1	1	2
N-glycosylase/DNA lyase	0	1	0	1
Chymotrypsinogen A	0	1	0	1
Dihydrofolate reductase	0	2	0	2
Potassium voltage-gated channel subfamily E member 1	0	1	0	1
Potassium voltage-gated channel subfamily KQT member 1	0	2	0	2
phosphoethanolamine/phosphocholine phosphatase isoform 1	0	1	0	1
Microtubule-associated protein tau	0	1	0	1
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	1	0	0	1
Fatty acid synthase	0	3	0	3
WD repeat-containing protein 5	0	1	0	1
Histone-lysine N-methyltransferase 2A	0	1	0	1
Cytosolic endo-beta-N-acetylglucosaminidase	0	1	0	1
Indoleamine 2,3-dioxygenase 2	0	3	0	3
Gonadotropin-releasing hormone receptor	0	1	0	1
Gonadotropin-releasing hormone receptor	0	2	0	2
Synaptic vesicle glycoprotein 2A	0	2	0	2
WRN	2	0	0	2
integrase, partial	0	1	0	1
lens epithelium-derived growth factor p75	0	1	0	1
pyruvate kinase	3	0	0	3
hexokinase-4 isoform 1	2	0	0	2
glucokinase regulatory protein	2	0	0	2
DNA polymerase eta isoform 1	4	0	0	4
Polyphenol oxidase 2	0	1	0	4
Tyrosinase	0	1	0	1
Solute carrier family 15 member 1	0	1	0	1
SLC16A10 protein	0	0	0	4
Monocarboxylate transporter 10	0	0	0	4
phosphoglycerate kinase	2	0	0	2
Sigma non-opioid intracellular receptor 1	0	1	0	1
Catechol O-methyltransferase	0	1	0	1
5-hydroxytryptamine receptor 1E	0	2	0	2
Sodium-dependent dopamine transporter	0	1	0	1
Cysteinyl leukotriene receptor 1	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-2	0	2	0	2
Aromatase	0	1	0	1
Ribosyldihydronicotinamide dehydrogenase [quinone]	0	2	0	2
Nociceptin receptor	0	1	0	1
Melatonin receptor type 1A	0	2	1	3
Melatonin receptor type 1C	0	0	1	1
Melatonin receptor type 1A	0	1	1	2
Melatonin receptor type 1B	0	2	1	3
Melatonin receptor type 1C	0	1	1	2
Melatonin receptor type 1B	0	1	1	2
Nuclear factor erythroid 2-related factor 2	0	0	0	1
Dihydrofolate reductase	0	4	0	4
Dipeptidyl peptidase 4	0	1	1	2
Aldehyde oxidase 1	0	2	0	2
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Aminopeptidase	0	1	0	1
Chain A, Methionine aminopeptidase	0	1	0	1
S-ribosylhomocysteine lyase	0	1	0	1
Adenylate cyclase type 5	0	1	0	2
S-adenosylmethionine synthase isoform type-1	0	0	0	1
S-adenosylmethionine synthase isoform type-2	0	0	0	1
Nuclear receptor subfamily 1 group I member 2	0	0	1	1
6-phosphogluconate dehydrogenase, decarboxylating	0	1	0	1
Lactoperoxidase	0	1	0	1
5-hydroxytryptamine receptor 3B	0	2	0	2
Stromelysin-1	0	2	1	3
Matrilysin	0	1	0	1
Multidrug transporter MdfA	0	1	0	1
Matrix metalloproteinase-9	0	1	0	1
Protein-arginine deiminase type-4	0	3	0	3
Chain A, Probable serine/threonine-protein kinase pknB	0	1	0	1
DNA polymerase III, partial	2	0	0	2
nonstructural protein 1	0	1	0	1
LANA	0	0	0	1
phospholipase A2, group III	0	1	0	1
histone-lysine N-methyltransferase NSD2 isoform 1	0	0	0	1
tyrosine-protein kinase Yes	1	0	0	1
dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	0	0	1
rac GTPase-activating protein 1 isoform a	0	1	0	1
DNA repair protein RAD52 homolog isoform a	0	0	0	3
pyruvate kinase PKM isoform b	3	0	0	3
Glycoprotein hormones alpha chain	2	0	0	2
Proto-oncogene tyrosine-protein kinase ROS	0	1	0	1
Ornithine decarboxylase	3	0	0	4
DNA topoisomerase 2	0	0	0	1
Multidrug resistance-associated protein 1	0	3	1	5
DNA topoisomerase 2-beta	0	0	0	1
Tyrosine-protein kinase BTK	0	1	0	1
NEDD8-activating enzyme E1 regulatory subunit	0	0	1	1
Casein kinase II subunit alpha 3	0	1	0	1
NEDD8-activating enzyme E1 catalytic subunit	0	0	1	1
Single-stranded DNA cytosine deaminase	1	0	0	1
P2Y purinoceptor 12	0	1	0	1
Acyl-CoA desaturase 1	0	1	0	1
Histidine decarboxylase	0	0	3	3
Nociceptin receptor	0	1	0	1
Mu-type opioid receptor	0	1	0	1
UDP-glucuronosyltransferase 1A8	0	0	0	2
Nociceptin receptor	0	1	0	1
Neurotensin receptor type 1	0	0	1	1
Neurotensin receptor type 2	0	1	1	3
Myelin basic protein	0	0	1	1
Neurotensin receptor type 1	0	1	1	2
Neurotensin receptor type 1	0	2	2	5
Neurotensin receptor type 2	0	2	1	3
Sortilin	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-4	0	2	1	3
Acetylcholine receptor subunit alpha	0	2	1	3
Acetylcholine receptor subunit beta	0	2	1	3
Acetylcholine receptor subunit gamma	0	2	1	3
Acetylcholine receptor subunit delta	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-4	0	1	0	1
Acetylcholine receptor subunit beta-like 2	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-5	0	0	2	2
Neuronal acetylcholine receptor subunit alpha-7	0	3	0	3
Acetylcholine-binding protein	0	1	1	2
Neuronal acetylcholine receptor subunit beta-3	0	1	1	2
Neuronal acetylcholine receptor subunit alpha-6	0	1	1	2
Cytochrome P450 2A13	0	3	2	5
Neuronal acetylcholine receptor subunit alpha-5	0	2	0	2
Liver carboxylesterase B-1	0	1	0	1
Transient receptor potential cation channel subfamily A member 1	0	0	2	2
Neuronal acetylcholine receptor subunit beta-3	0	2	0	2
Neuronal acetylcholine receptor subunit beta-4	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-3	0	2	0	2
Soluble acetylcholine receptor	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-2	0	2	0	2
Neuronal acetylcholine receptor subunit beta-2	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-6	0	2	0	2
Integrin beta	0	0	1	1
Glycoprotein IIb	0	0	1	1
perilipin-5	0	1	0	1
perilipin-1	0	1	0	1
eyes absent homolog 2 isoform a	1	0	0	1
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a	0	1	0	1
Phospholipase A2, membrane associated	0	0	0	1
Potassium voltage-gated channel subfamily A member 5	0	1	0	1
Platelet-activating factor receptor	0	0	0	1
C-C chemokine receptor type 2	0	2	0	2
Voltage-dependent L-type calcium channel subunit alpha-1C	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1S	0	1	0	1
C-terminal-binding protein 1	1	0	0	1
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	1	0	1
Myosin light chain kinase, smooth muscle	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1D	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1F	0	1	0	1
Sodium- and chloride-dependent betaine transporter	0	1	0	1
STE24	0	0	0	1
CAAX prenyl protease	0	0	0	1
Trypsin	0	0	0	1
FAD-linked sulfhydryl oxidase ALR	0	0	0	1
Glucose-6-phosphate 1-dehydrogenase	0	1	0	1
Interleukin-6 receptor subunit alpha	0	1	0	1
Thyrotropin-releasing hormone receptor	0	1	0	1
Glycine receptor subunit alpha-4	0	1	0	1
Leukotriene B4 receptor 1	0	1	0	1
Glyceraldehyde-3-phosphate dehydrogenase	0	1	0	1
DNA repair protein RAD52 homolog	0	1	0	1
MBT domain-containing protein 1	0	1	0	1
Lethal(3)malignant brain tumor-like protein 4	0	1	0	1
Lethal(3)malignant brain tumor-like protein 3	0	1	0	1
Lethal(3)malignant brain tumor-like protein 1	0	1	0	1
Oxytocin receptor	0	0	1	1
Phenylethanolamine N-methyltransferase	0	1	0	1
Beta-adrenergic receptor kinase 1	0	1	0	1
Potassium voltage-gated channel subfamily A member 3	0	2	0	2
Beta-adrenergic receptor kinase 1	0	1	1	2
Substance-P receptor	0	3	1	4
Rhodopsin kinase GRK1	0	1	0	1
G protein-coupled receptor kinase 5	0	1	0	1
G protein-coupled receptor kinase 5	0	1	0	1
P2X purinoceptor 4	0	1	0	1
Rhodopsin kinase GRK1	0	1	0	1
Beta-adrenergic receptor kinase 1	0	0	0	1
bcl-2-related protein A1	0	1	0	1
Aldehyde oxidase 1	0	1	0	1
Retinal dehydrogenase 1	0	1	0	1
Aldehyde oxidase 1	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Flavodoxin	0	0	0	1
Membrane primary amine oxidase	0	0	0	1
Cationic trypsin	0	1	0	1
Membrane primary amine oxidase	0	0	0	1
Lysyl oxidase homolog 2	0	1	0	1
Aldo-keto reductase family 1 member B1	0	3	0	3
Chain A, AMINOPEPTIDASE	0	1	0	1
Chain A, AMINOPEPTIDASE	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	2	0	2
Alkaline phosphatase, tissue-nonspecific isozyme	0	1	0	1
Intestinal-type alkaline phosphatase	0	2	0	2
Intestinal-type alkaline phosphatase	0	1	0	1
5'-nucleotidase	0	1	0	1
E3 ubiquitin-protein ligase XIAP	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	1	0	1
Phospholipase A-2-activating protein	0	2	0	2
Dihydrofolate reductase	0	1	0	1
Acetylcholinesterase	0	1	0	1
XBP1	0	1	0	1
nuclear factor NF-kappa-B p105 subunit isoform 1	3	0	0	3
DNA damage-inducible transcript 3 protein	0	1	0	1
Ubiquitin carboxyl-terminal hydrolase 1	0	2	0	2
WD repeat-containing protein 48	0	2	0	2
Muscarinic acetylcholine receptor DM1	0	1	0	1
Muscarinic acetylcholine receptor M5	0	1	0	1
Muscarinic acetylcholine receptor M3	0	1	0	1
Muscarinic acetylcholine receptor M2	0	1	0	1
Nuclear receptor subfamily 1 group I member 3	0	1	0	1
luciferase	0	0	0	1
Glucocorticoid receptor	0	1	1	2
Glucocorticoid receptor	0	0	1	1
Glutamine synthetase	0	0	1	1
Nociceptin receptor	0	0	1	1
Estrogen receptor beta	0	2	0	2
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	1	0	2
Voltage-dependent calcium channel subunit alpha-2/delta-2	0	1	0	1
Solute carrier family 22 member 8	0	1	0	1
Solute carrier family 22 member 7	0	1	0	2
Canalicular multispecific organic anion transporter 1	0	1	0	1
Pannexin-1	0	1	0	1
Solute carrier family 22 member 12	0	1	0	1
Solute carrier organic anion transporter family member 1C1	0	2	0	2
UDP-glucuronosyltransferase 1A7	0	1	0	1
UDP-glucuronosyltransferase 1A10	0	1	0	1
Pannexin-1	0	1	0	1
Solute carrier family 22 member 11	0	2	0	2
Solute carrier family 22 member 7	0	2	0	2
Chloroquine resistance transporter	0	2	0	2
Endothelin-1 receptor	0	1	1	2
Neuromedin-K receptor	0	0	1	1
Type-1 angiotensin II receptor	0	1	1	2
Cholecystokinin receptor type A	0	1	1	2
Beta-1 adrenergic receptor	0	1	0	1
Sodium/bile acid cotransporter	0	2	0	2
Nuclear receptor subfamily 2 group E member 1	0	0	2	2
Pyridoxal kinase	0	0	0	1
Dipeptidyl peptidase 4	0	0	1	1
lethal(3)malignant brain tumor-like protein 1 isoform I	1	0	0	1
caspase-1 isoform alpha precursor	2	0	0	2
DNA dC->dU-editing enzyme APOBEC-3F isoform a	1	0	0	1
DNA topoisomerase 1	0	2	0	2
Chromaffin granule amine transporter	0	1	0	1
Synaptic vesicular amine transporter	0	3	1	4
Synaptic vesicular amine transporter	0	2	0	2
Ribonuclease HI	0	1	0	1
Chain A, 6,7-Dimethyl-8-ribityllumazine Synthase	0	0	1	1
Chain B, 6,7-Dimethyl-8-ribityllumazine Synthase	0	0	1	1
Chain A, Breast cancer type 1 susceptibility protein	1	0	0	1
Chain H, Immunoglobulin Igg1 Heavy chain	0	0	1	1
Chain L, Immunoglobulin Igg1 Lambda Light Chain	0	0	1	1
Chain A, DODECIN	0	0	1	1
Chain A, DODECIN	0	0	1	1
Chain C, DODECIN	0	0	1	1
Chain E, DODECIN	0	0	1	1
NPYLR7B	0	0	1	1
Riboflavin-binding protein	0	1	1	2
Pteridine reductase 1	0	2	0	2
Chain A, HIV-1 PROTEASE	0	1	0	1
Chain B, HIV-1 PROTEASE	0	1	0	1
Chain A, Endothiapepsin	0	1	0	1
Chain A, Endothiapepsin	0	1	0	1
Solute carrier organic anion transporter family member 2B1	0	2	0	2
Gag-Pol polyprotein	0	1	0	1
Plasmepsin V	0	1	0	1
Estrogen receptor beta	0	1	0	2
Inhibitor of nuclear factor kappa-B kinase subunit beta	0	0	0	1
5'-AMP-activated protein kinase subunit beta-2	0	0	0	1
Polymerase acidic protein	0	0	1	1
Tyrosine-protein phosphatase YopH	0	1	0	1
High mobility group protein B1	0	0	1	1
Estrogen receptor	0	1	0	2
Cystathionine gamma-lyase	0	1	0	1
5'-AMP-activated protein kinase subunit gamma-1	0	0	0	1
5'-AMP-activated protein kinase catalytic subunit alpha-2	0	0	0	1
Xanthine dehydrogenase/oxidase	0	1	0	1
5'-AMP-activated protein kinase catalytic subunit alpha-1	0	0	0	1
Carbonic anhydrase	0	1	0	1
Ubiquitin-like domain-containing CTD phosphatase 1	0	1	0	1
5'-AMP-activated protein kinase subunit gamma-3	0	0	0	1
5'-AMP-activated protein kinase subunit gamma-2	0	0	0	1
5'-AMP-activated protein kinase subunit beta-1	0	0	0	1
Adenylate cyclase type 6	0	1	0	1
Adenylate cyclase type 3	0	1	0	1
Adenylate cyclase type 9	0	1	0	1
D(1) dopamine receptor	0	1	0	1
Adenylate cyclase type 8	0	1	0	1
Adenylate cyclase type 7	0	1	0	1
Adenylate cyclase type 2	0	1	0	1
Adenylate cyclase type 4	0	1	0	1
Cytochrome P450 2B1	0	1	0	1
Type-1 angiotensin II receptor	0	1	0	1
C-X-C chemokine receptor type 3	0	1	0	1
Amine oxidase [flavin-containing] A	0	0	0	1
Amine oxidase [flavin-containing] B	0	0	0	1
Pyruvate kinase PKM	0	0	1	1
Transcriptional activator protein LuxR	0	1	0	1
alternatively spliced Trp4	0	0	1	1
5-hydroxytryptamine receptor 1E	0	1	0	1
sphingosine 1-phosphate receptor 3	0	1	0	1
Beta-casein	0	1	0	1
D(3) dopamine receptor	0	1	0	1
5-hydroxytryptamine receptor 7	0	1	0	1
D(4) dopamine receptor	0	1	0	1
D(1B) dopamine receptor	0	1	0	1
Tissue factor	0	2	0	2
Neuromedin-K receptor	0	0	1	1
Substance-K receptor	0	1	1	2
Neuromedin-K receptor	0	1	1	2
Substance-K receptor	0	1	0	1
Substance-K receptor	0	1	0	1
Growth hormone secretagogue receptor type 1	0	0	1	1
Carbonic anhydrase	0	2	0	2
D(2) dopamine receptor	0	1	0	1
Cathepsin D	0	1	0	1
Mucosa-associated lymphoid tissue lymphoma translocation protein 1	0	1	0	1
Chain X, Thyroid hormone receptor beta-1	0	0	2	2
Chain X, Thyroid hormone receptor beta-1	0	0	2	2
Solute carrier organic anion transporter family member 1A5	0	0	0	2
Transthyretin	0	1	0	3
Thyroid hormone receptor alpha	0	2	3	5
Thyroid hormone receptor beta	0	2	3	5
Proliferating cell nuclear antigen	0	2	0	2
Retinoic acid receptor RXR-alpha	0	2	4	6
Malate dehydrogenase, mitochondrial	0	1	0	1
Solute carrier organic anion transporter family member 1A2	0	0	0	2
Solute carrier organic anion transporter family member 1A3	0	0	0	2
Monocarboxylate transporter 8	0	0	0	1
Bile acid receptor	0	1	0	1
Solute carrier organic anion transporter family member 1C1	0	0	0	1
Chain A, Carbonic anhydrase 1	0	1	0	1
Prolyl endopeptidase	0	1	0	1
Carbonic anhydrase-related protein 11	0	0	0	1
Arachidonate 5-lipoxygenase-activating protein	0	1	0	1
Carbonic anhydrase 5A, mitochondrial	0	1	0	1
Carbonic anhydrase 2	0	1	0	1
Cytochrome P450 2E1	0	1	0	1
Cytochrome P450 4B1	0	1	0	1
Cytochrome P450 2A7	0	1	0	1
Cytochrome P450 2F1	0	1	0	1
Cytochrome P450 2C18	0	1	0	1
Cytochrome P450 4F2	0	1	0	1
Cytochrome P450 4F8	0	1	0	1
Cytochrome P450 4A11	0	1	0	1
Cytochrome P450 4F3	0	1	0	1
Cytochrome P450 4A22	0	1	0	1
Vitamin D 25-hydroxylase	0	1	0	1
Cytochrome P450 2U1	0	1	0	1
Cytochrome P450 2W1	0	1	0	1
Cytochrome P450 2S1	0	1	0	1
Cytochrome P450 3A43	0	1	0	1
REST corepressor 3	0	1	0	1
Chain A, Nuclear Receptor ROR-beta	0	1	0	1
Ornithine decarboxylase	0	0	0	1
Retinoic acid receptor alpha	0	2	2	7
Retinoic acid receptor beta	0	2	2	7
Retinoic acid receptor alpha	0	1	2	3
Retinoic acid receptor gamma	0	2	2	7
Retinoic acid receptor gamma	0	1	2	3
Retinoic acid receptor beta	0	1	2	3
Cellular retinoic acid-binding protein 2	0	0	1	1
Mitogen-activated protein kinase 1	0	1	0	1
Retinoic acid receptor RXR-alpha	0	1	2	3
Retinoic acid receptor RXR-beta	0	2	2	4
Retinoic acid receptor RXR-beta	0	1	2	3
Retinoic acid receptor RXR-gamma	0	1	2	3
Nuclear receptor ROR-alpha	0	1	0	1
Cellular retinoic acid-binding protein 1	0	1	0	2
Retinoic acid receptor RXR-gamma	0	2	2	4
Cellular retinoic acid-binding protein 1	0	0	1	1
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	0	2	1	3
Nuclear receptor ROR-beta	0	1	0	1
Genome polyprotein	0	1	0	1
DNA dC->dU-editing enzyme APOBEC-3G isoform 1	1	1	0	2
Lysozyme C-1	0	1	0	1
Protein kinase C alpha type	0	1	0	1
Beta-glucuronidase	0	1	0	1
Protein kinase C delta type	0	1	0	1
Protein kinase C epsilon type	0	1	0	1
Protein kinase C zeta type	0	1	0	1
Protein kinase C gamma type	0	1	0	1
Protein kinase C beta type	0	1	0	1
Protein kinase C eta type	0	1	0	1
Calcium-dependent protein kinase 4	0	1	0	1
Emopamil-binding protein-like	0	1	0	1
Protein kinase C theta type	0	1	0	1
Thyroid hormone receptor beta	0	1	0	1
Solute carrier organic anion transporter family member 4A1	0	0	0	1
Vif	0	1	0	1
Tat	0	1	0	1
Indoleamine 2,3-dioxygenase 1	0	2	0	3
Strictosidine synthase	0	0	0	1
Cathepsin K	0	1	0	1
Chain A, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain K, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain B, tryptophanyl-tRNA synthetase	0	0	1	1
Chain C, Tryptophanyl-tRNA synthetase II	0	0	1	1
Tryptophan 2,3-dioxygenase	0	1	0	2
Tryprostatin B synthase	0	0	0	1
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase	0	0	1	1
Trp operon repressor	0	0	1	1
Chain A, CHORISMATE MUTASE	0	1	0	1
Chain A, TYROSYL-tRNA SYNTHETASE	0	0	1	1
Tubulin--tyrosine ligase	0	1	0	1
Taste receptor type 2 member 14	0	0	0	1
Solute carrier family 2, facilitated glucose transporter member 9	0	1	1	2
Chain A, Arginase 1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member B7	0	1	0	1
NAD-dependent protein deacylase sirtuin-5, mitochondrial	0	1	0	1
Glycoprotein	0	1	0	1
Catechol O-methyltransferase	0	1	0	1
Proprotein convertase subtilisin/kexin type 7	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	2	0	2
Alpha-2A adrenergic receptor	0	1	0	1
M-phase inducer phosphatase 1	0	1	0	1
Lysosomal alpha-glucosidase	0	1	0	1
Aspartate aminotransferase, cytoplasmic	0	1	0	1
twin arginine protein translocation system - TatA protein	0	0	0	1
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Chronic Motor and Vocal Tic Disorder

Synonyms(14)

Research Excerpts

Overview

Context

Treatment

Research

Studies (1,275)

Protein Targets (1,712)

Chronic Motor and Vocal Tic Disorder

Synonyms(14)

Research Excerpts

Overview

Context

Treatment

Research

Studies (1,275)

Drugs Studied (361)

Protein Targets (1,712)